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1 Introduction 
 
1.1 Peripheral nerve lesions - Axon-Schwann cell interactions 
Neurons of the peripheral nervous system (PNS) are able to regenerate after nerve injury. This 
is in contrast to neurons of the central nervous system (CNS; Ramón y Cajal, 1914). Crushing 
or cutting a peripheral nerve triggers a well characterized cascade of cellular and molecular 
events, collectively described as Wallerian degeneration, throughout the distal extent of that 
nerve. This process involves a number of phases in which the distal portions of all affected 
axons, irrespective of size and modality, degenerate and disappear. Within two days 
associated myelin sheaths are degraded. Recruited macrophages invade the distal segment and 
remove axonal and myelin debris. Schwann cells proliferate showing a maximum after 3 – 4 
days leading to steadily increasing numbers up to day 14 after lesion (Oaklander, 1988). The 
de-differentiated daughter cells line up within each basal lamina tube to form the bands of 
Büngner and become permissive for regeneration. Proximal to the site of injury, axons give 
rise to one or more sprouts, each of which is tipped by a growth cone (Ramón y Cajal, 1928). 
For axonal regeneration to be successful, growth cones must first reach the distal nerve stump, 
which is even possible when they have to cross a gap between the proximal and distal nerve 
stumps. Growth cones then contact the basal lamina, and Schwann cells that re-differentiate 
after a second burst of proliferation induced by ingrowing axons enwrap the ingrowing axon 
forming a new myelin sheath (Fawcett and Keynes, 1990; Fig. 1.1).  
Schwann cells have long been known to be central players in Wallerian degeneration and 
subsequent regeneration. A differentiated axon-associated Schwann cell is a polarized cell 
with a basal, abaxonal surface apposed to a basal lamina (which it secretes), an apical surface 
apposed to an axon or group of axons, and lateral surfaces tipped with microvilli, which 
interdigitate with adjacent Schwann cells. Functionally, they have been defined almost 
entirely in terms of their reciprocal relationships with the axons they ensheathe. Axonal 
signals, whether acting by direct contact or diffusible molecules, regulate the expression of 
many Schwann cell genes and control both proliferation and differentiation of these cells 
(Bolin and Shooter, 1993; Jessen and Richardson, 2001; Lemke and Chao, 1988; Maurel and 
Salzer, 2000; Thomson et al., 1993). The relative contributions of the Schwann cells and their 
basal laminae have been evaluated in vivo by comparing regeneration in cellular versus a-
cellular nerves: PNS axons will regenerate also in a-cellular nerve grafts, but regeneration is 
better in nerves that contain living Schwann cells (Sketelj et al., 1989). 
 2
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.1: Changes in peripheral nerve during Wallerian degeneration. a: Schwann cells 
surrounded by a basal lamina enwrap an uninjured axon. b: A few days after injury, the axon 
and its myelin sheath degenerate distal to the lesion site, Schwann cells proliferate and 
macrophages invade the distal nerve stump to phagocytose myelin debris. c: A few weeks 
later, the regenerating axon has been re-myelinated by Schwann cells. Jessen, 2001. 
 
After axotomy this tightly regulated relationship between axons and Schwann cells is 
disrupted. Acutely denervated Schwann cells downregulate transcripts of myelin-specific 
proteins, like myelin-associated glycoprotein (MAG), myelin basic protein, protein P0, 
periaxin, peripheral myelin protein 22kD, plasmolipin, and the fatty acid-binding protein P2 
(Gillen et al., 1997; Mitchell et al., 1990; Willison et al., 1988). They also reduce the 
expression of connexin 32, a gap junction protein which forms reflexive contacts within 
individual myelinating Schwann cells at paranodes and incisures (Arroyo and Scherer, 2000; 
Chandross, 1998), and caveolin-1, a putative regulator of signal transduction and/or 
cholesterol transport in myelinating Schwann cells (Nishio et al., 2002). De-differentiated 
proliferating Schwann cells upregulate gene expression of the low affinity neurotrophin 
receptor p75 (Heumann et al., 1987a; Heumann et al., 1987b; Taniuchi et al., 1986), GAP-43 
(Curtis et al., 1992), nerve growth factor (NGF; Matsuoka et al., 1991), brain-derived 
neurotrophic factor (BDNF; Korsching, 1993; Meyer et al., 1992), the neuregulin receptors 
erbB2, erbB3 and erbB4 (Cohen et al., 1992; Li et al., 1997a; Li et al., 1998), N-CAM and L1 
(Jessen et al., 1987; Martini and Schachner, 1988). They increase the expression of laminin 
(Kuecherer-Ehret et al., 1990), tenascin (Martini et al., 1990), fibronectin (Lefcort et al., 
1992), the neuropoietic cytokines leukemia inhibitory factor (LIF) and interleukin-6 (IL-6; 
Kurek et al., 1996), and netrin-1, a secreted protein which influences growth cone and axon 
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guidance (Madison et al., 2000). Gene expression of the gap junction protein connexin 43, 
which may mediate junctional coupling in de-differentiated Schwann cells and so facilitate 
the rapid diffusion of signaling molecules between cells downstream of the lesion site 
(Chandross, 1998) and TGFβ-1 (Scherer et al., 1993) is also upregulated by proliferating 
Schwann cells. These changes in gene expression mean that acutely denervated Schwann cells 
are in a reactive, axon-responsive state in the first weeks after injury. Re-innervated Schwann 
cells cease dividing, downregulate expression of the molecules listed above and revert to an 
axon-associated phenotype. 
 
1.2 Retinoic acid and axonal regeneration 
Schwann cells are the most important modulators of axonal regeneration. They are the main 
source of trophic factors that promote regeneration after peripheral nerve injury. It is still 
unknown how these trophic factors themselves are modulated. My hypothesis is that retinoic 
acid (RA), a transcriptional regulator of gene expression, whose importance in embryonic 
development is well established (Ross et al., 2000), is one of the factors that control Schwann 
cell reactions after nerve injury. All necessary components of the RA signal transduction 
pathway are detectable in mammalian peripheral nerves. Among the molecular targets that are 
known to be expressed by Schwann cells and regulated by RA in various cell culture systems 
unrelated to the nervous system (Mey, 2001) are neuropoietic cytokines, neurotrophins and 
members of the transforming growth factor-β (TGFβ) family. They all belong to a diverse 
group of proteins with small molecular weight (6-26 kDa), secreted by all cell types that 
participate in traumatic interactions after nerve injury (Zhao and Schwartz, 1998), and they 
are known to be regulated early after sciatic nerve crush or transection (Gillen et al., 1997). 
The neurotrophin family consists of four members in mammals: NGF, BDNF, neurotrophin 
(NT)-3 and NT-4 (Ip and Yancopoulos, 1996; Korsching, 1993; Lewin and Barde, 1996; 
Snider, 1994). Each neurotrophin binds selectively to high-affinity neurotrophin receptors, 
TrkA (tyrosin kinase), TrkB and TrkC and non-selectively to the low-affinity neurotrophin 
receptor p75 (Ip and Yancopoulos, 1996). Upon binding their cognate neurotrophin(s), Trk 
receptors dimerize and are autophosphorylated via their intracellular kinase domain; this, in 
turn, activates various intracellular signaling pathways including Ras, phosphatidylinositol 3-
kinase and phospholipase Cγ (Segal and Greenberg, 1996; Skaper and Walsh, 1998).  
In mammals, the TGFβ family is comprised of three isoforms termed TGFβ1, -β2 and -β3. 
They initiate their cellular action by binding to heterodimeric receptors type I and type II, 
with intrinsic serine/threonine kinase activity (Wrana et al., 1994). The TGF receptors 
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phosphorylate SMAD transcription factors, which translocate from the cytoplasm to the 
nucleus (Heldin et al., 1997). 
Ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF) and IL-6 belong to the 
neuropoietic cytokines that share the common membrane receptor subunit gp130. Their 
receptor complex contains gp130 plus one or two more specific receptor subunits. Receptors 
signal through the Jak-Stat pathway, in which cytoplasmic STAT proteins translocate into the 
nucleus and act as transcription factors (Ip and Yancopoulos, 1996). 
Schwann cells synthesize NGF (Heumann et al., 1987a; Heumann et al., 1987b), BDNF 
(Funakoshi et al., 1993), GDNF (Iwase et al., 2005), all three TGF-βs (Mews and Meyer, 
1993), CNTF (Sendtner et al., 1992b), LIF (Curtis et al., 1993b) and IL-6 (Grothe et al., 
2000). After peripheral nerve lesion their expression is differentially regulated: NGF mRNA 
is upregulated early in Schwann cells after axotomy, while BDNF expression is induced 
rather late. It has been suggested that NGF promotes sprouting, but not axonal regeneration 
(Diamond et al., 1992a, b; Gloster and Diamond, 1992). BDNF, NT-3 and NT-4 support the 
survival of motoneurons in culture, after neonatal axotomy and in animal models of motor 
neuron disease (Elliott and Snider, 1996; Oppenheim, 1996). The level of TGF-β1 mRNA 
increases, whereas the expression of TGF-β3 mRNA falls during Wallerian degeneration. It 
has been suggested that increases in TGF-β expression in the distal nerve stump enhance 
axonal regeneration by promoting a non-myelinating Schwann cell phenotype as well as 
macrophage infiltration (Jessen and Richardson, 2001). LIF mRNA expression increases after 
axotomy in the distal nerve (Sendtner et al., 1992). LIF is retrogradely transported in the 
axons and functions as a neurotrophic factor for sensory and motoneurons (Matsuoka et al., 
1997). CNTF is downregulated after sciatic nerve lesion, but is released from damaged cells 
and exerts a neurotrophic effect on motoneurons (Curtis et al., 1993; Sendtner et al., 1992). 
IL-6 and IL-6Rα are also upregulated after axotomy distal to the injury (Bolin et al., 1995; Ito 
et al., 1998; Reichert et al., 1996), and IL-6 seems to promote axonal regeneration of motor 
axons (Hirota et al., 1996). 
The way how RA exerts its regulatory functions after nerve lesion may involve different 
mechanisms. 1. They could include changes in expression of RA signaling molecules: CRBP-
I and CRABP-II are strongly upregulated after sciatic nerve injury. Its transcript levels rose 
10- and 15-fold (Zhelyaznik et al., 2003). The expression of RARα, RARβ and RXRα rose 
after injury (Zhelyaznik and Mey, 2005). 2. RA synthesis is increased: in a transgenic reporter 
mouse a local activation of RA responsive elements was induced by sciatic nerve crush and 
RALDH2 was found to be biologically active (Zhelyaznik et al., 2003). 3. Modifications in 
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the intracellular localization of CRABP-II which transports RA into the nucleus (Budhu and 
Noy, 2002; Dong et al., 1999) and of retinoid receptors which act as transcription factors, may 
directly influence the transcriptional activity of RA. 
 
1.3 CNS lesions - Spinal cord injuries 
Although CNS axons have an intrinsic capacity to regenerate in vivo (David and Aguayo, 
1981; Li et al., 1997b) or in vitro (Naumann et al., 1992; Schubert et al., 2005), if provided 
with the correct environment, several factors account for the regenerative failure seen in the 
adult CNS. Two circumstances unique to the CNS block regeneration: 1. The glial scar 
presents a physical, impenetrable barrier to regeneration and contains several inhibitory 
molecules associated with the extracellular matrix such as chondroitin sulphate proteoglycans 
(Lepore and Fischer, 2005; McKeon et al., 1991). 2. In the white matter, a regenerating axon 
will encounter many myelin-associated molecules expressed on the membrane surface or 
released after damage that can inhibit regeneration (Fig.1.2). These include Nogo (Caroni and 
Schwab, 1988; Chen et al., 2000), MAG (McKerracher et al., 1994; Mukhopadhyay et al., 
1994) and oligodendrocyte-myelin glycoprotein (Wang et al., 2002; Kottis et al., 2002). 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.2: Among several factors that prevent regeneration in the CNS environment the glial 
scar and myelin associated molecules are the most prominent. Modified after Spencer, 2003. 
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Spinal cord injuries (SCI) can occur due to a number of different insults, generally classified 
as a-traumatic and traumatic injuries. A-traumatic SCI mostly result from tumors exerting 
continuous pressure on the cord, but can also be caused by vascular disturbances or infections 
(Pelser and van Gijn, 1993; Svensson et al., 1993). In traumatic SCI, the cord is subjected to 
mechanical stress. Here, the resultant injury is dependent upon the intensity and direction of 
the force, and the vertebral level the force is applied to. Lesion can result in either paraplegia 
(paralysis of the lower body) or quadriplegia (paralysis of the whole body from the neck 
down), depending on whether the injury was received in the thoracic/lumbar region or neck 
region of the spinal column. The most common type of traumatic SCI is a spinal cord 
contusion injury. It is mostly caused by motor vehicle accidents, diving into shallow water or 
sport accidents. It is induced by a relatively short pressure on, or stretching of the cord (Tator 
and Edmonds, 1979) most often at cervical and thoracal levels of C5 – C6 (~60 %) and T12 – 
L1 (~25 %; Tator, 1983). 
After a CNS lesion, two phases of injury can be distinguished: (1) the primary damage 
consists of the mechanical tissue destruction. (2) It initiates a cascade of events that further 
harm the spinal cord and are mainly caused by local interruption of the blood supply (Dumont 
et al., 2001; Schwab and Bartholdi, 1996). This secondary damage leads to further extension 
of the lesion, followed by cyst and glial scar formation (Fig.1.3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.3: Rat spinal cords after injury. The epicenter of the lesion can be detected as early as 
15 min after injury (asterisk). Necrosis associated with it progressed up to 3 days after injury 
(double asterisks). Reduction of the necrosis was observed at 7 and 14 days after injury. Yan, 
1999. 
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The ultimate goal in the treatment of SCI is the complete protection of the spinal cord and its 
functions after injury (acute phase), and the restoration of lost functions (subacute and chronic 
phase). In the acute phase, research focuses on reduction of secondary damage, thereby 
minimizing the loss of function, with neuroprotective agents. Of these only the synthetic 
corticosteroid methylprednisolone, which has to be given at high dosage within 8 hours after 
injury to improve neurological outcome, is in use clinically (Bracken and Shepard, 1998; 
Schwab and Bartholdi, 1996). It is known to reduce lipid peroxidation, lessen edema and 
inflammation, lower excitatory amino acid release, and inhibit tumor necrosis factor-α 
(TNFα) expression and nuclear factor-kappa B (NF-κB) activation (Oudega et al., 1999). In 
the subacute and chronic phase, stimulation of axonal outgrowth is the goal of medical 
research: Since complete disruption of the cord is rare after SCI, bridges of nerve tissue that 
connect regions above and below the lesion often persist, and neurons often exhibit an 
initiative regenerative response, as evidenced by an upregulation of immediate early genes, 
cytosceletal proteins and the growth associated protein B50 (GAP43). However, ultimately 
this regenerative response fails and is followed by a downregulation of growth-associated 
genes, leaving the neurons in an atrophic state (Linda et al., 1993; Nacimiento et al., 1995; 
Schwab and Bartholdi, 1996; Theriault et al., 1992). Strategies to promote re-growth and 
restore functions therefore involve multiple approaches like bridges that form growth-
permissive scaffolds within the lesion site, blocking of inhibitory molecules and 
pharmacological stimulation with axonal growth promoting substances. Implantation of 
pieces of peripheral nerve (Cheng et al., 1996), fetal tissue (Bregman et al., 2002), olfactory 
ensheathing glia (Boyd et al., 2003; Santos-Benito and Ramón-Cueto, 2003) and Schwann 
cell bridges (Bunge, 2001) have been assessed. Enzymes were delivered to overcome 
inhibitory factors that prevent the formation of or degrade chondroitin sulphate proteoglycans 
as they accumulate near the site of injury (Bradbury et al., 2002; Yick et al., 2000). In order to 
enable the axons to grow through an inhibitory milieu, surface receptors on growing nerve 
fibers that respond to inhibitory factors were blocked by antibodies to the inhibitory factors 
(Schwab, 2002) or fragments thereof (Fiedler et al., 2002) or by introducing competitive 
antagonists (GrandPré et al., 2002),. Transplants are often tested in conjunction with the 
neurotrophins BDNF and neurotrophin 3 (NT-3). These neurotrophins have been shown to 
increase axonal growth into transplants (Bregman et al., 2002; Jones et al., 2001; Murray et 
al., 2002) and to promote the growth of regenerating axons from transplants into the spinal 
cord (Bamber et al., 2001; Oudega and Hagg, 1999). These data demonstrate CNS plasticity 
after trauma and give hope for future treatments of spinal cord lesions. 
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1.4 Retinoic acid signaling after spinal cord injury 
After spinal cord injury, microglia and macrophages clear debris from degenerating cells and 
myelin and secrete a number of inflammatory cytokines. Due to these functions microglia has 
a decisive influence on the medical outcome after spinal cord injury (Kiefer et al., 2001; Yang 
et al., 2005; Batchelor et al., 2004; Gomes-Leal et al., 2004), and differences in the 
inflammatory reaction between CNS and PNS have been suggested to be responsible for the 
different growth promoting properties of these environments (Lazarov-Spiegler et al., 1998; 
Slovodov et al., 2000; Stoll et al., 2002). 
The putative relevance of the RA signaling system for CNS injury rests on three kinds of ob-
servations: (1) A subpopulation of proliferating cells that express the proteoglycan NG-2 as 
well as RALDH2 were specifically observed in the vicinity of a spinal cord contusion, and 
RA-synthesizing activity by those enzymes increased locally after the lesion (Mey et al., 
2005). (2) Corcoran, Maden and coworkers (2002a) found a strong correlation between 
axonal regeneration and the expression of RARβ2: Embryonic mouse spinal cord tissue 
extended neurites after application of RA in vitro and this correlated with the expression of 
RARβ2, whereas tissue from adult mouse spinal cord did not regenerate neurites and did not 
show an upregulation of RARβ2. Adult spinal cord tissue which was transfected to over-
express RARβ2 showed prolific neurite outgrowth in vitro. (3) In retinoid-deficient adult rats, 
motoneurons showed an accumulation of intracellular neurofilaments, vacuoles and an 
increase in astrocytosis, associated with motoneuron disease. These effects were ascribed to 
the failed activation of RARα (Corcoran et al., 2002b). 
 
1.5 The retinoic acid signaling system 
Retinoic acid (RA) is the bioactive metabolite of vitamin A (retinol) which acts on cells to 
establish or change the pattern of gene activity. Vitamin A that is obtained from the diet is 
stored in the liver in the form of retinyl esters (Blomhoff, 1994). For release, the esters are 
hydrolyzed to retinol, which is released into the bloodstream for transport within the body 
bound to plasma retinol-binding protein. Cells which require RA take up retinol and convert it 
to RA through the action of two types of enzymes, retinol dehydrogenases (ROLDH) and 
retinaldehyde dehydrogenases (RALDH; Duester, 1996; Napoli, 1996). In addition, there are 
cytochrome P450 enzymes known as CYP26 which  break down all-trans-RA to 4-oxo-RA, 
4-hydroxy-RA and 18-hydroxy-RA (Abu-Abed et al., 1998; White et al., 1996; White et al., 
1997) or 5,8-epoxy-RA (Fujii et al., 1997). Most of these breakdown products are thought to 
be inactive metabolites on their way to being excreted.  
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Cellular retinol binding proteins (CRBP-I and -II) and cellular retinoic acid binding proteins 
(CRABP-I and -II) bind retinol (CRBP-I), retinol and retinaldehyde (CRBP-II), and RA 
(CRABP-I and –II), and are members of the fatty acid-binding protein super-family. CRBPs 
facilitate retinol uptake into the target cell and direct the intracellular metabolism of retinol to 
retinyl esters (storage form) or RA (only CRBP-I) (Napoli, 1996). CRABPs are hypothesized 
to solubilize and protect RA in the aqueous cytosol and to act as shuttles to move lipophilic 
RA to various subcellular compartments. Both CRABP-I and -II are found mainly in the 
cytosol but have also been reported to be present in the nucleus (Gaub et al., 1998). With 74% 
sequence identity the two CRABP isoforms are highly homologous and are also extremely 
conserved between species. The CRABPs belong to the family of intracellular lipid-binding 
proteins, which comprises small (~15 kDa) proteins that bind to a variety of lipophilic ligands 
(Noy, 2000). They are thought to regulate the ability of RA to bind to its receptors and 
thereby alter gene transcription (Delva et al., 1999; Dong et al., 1999; Yamamoto et al., 
1998). Kinetic studies of the movement of RA to RAR show that CRABP-I is a passive 
vehicle, binding and releasing its ligand depending on concentration gradients. CRABP-I 
appears to decrease cellular responses to RA by catalyzing its degradation and thereby 
lowering active intracellular RA concentrations (Boylan and Gudas, 1992). In contrast, 
CRABP-II appears to increase RA-mediated gene transcription and sensitizes cells to the 
effects of RA (see 2.4). 
The biological activity of RA is mediated by interaction with retinoid receptors, which are 
ligand-activated transcription factors within the nuclei of RA-sensitive cells. They form part 
of the gene super-family including the steroid hormone receptors. There are two classes of 
these transcription factors, the retinoic acid receptors (RAR) and retinoid X receptors (RXR), 
each of which consist of three subtypes, (α, β and γ) with several isoforms of each of these six 
genes, formed by differential promoter usage (Chambon, 1996). This complexity gives rise to 
numerous receptor combinations as RAR exist as heterodimers with RXR. RXR can 
heterodimerize with numerous other nuclear receptor proteins including thyroid hormone 
receptors (TR), vitamin D receptor (VDR), and peroxisomal proliferator-activated receptor 
(PPAR; Bugge et al., 1992; Kliewer et al., 1992). Activation of the RAR-RXR heterodimer is 
controlled by RAR because RXR-selective ligands do not induce gene transcription 
(Kurokawa et al., 1994). However, once an RAR ligand is bound, RXR ligands can increase 
transcriptional efficiency of the RAR-RXR heterodimer (Minucci et al., 1997). As with all 
nuclear receptors, the RAR and RXR contain a DNA-binding and a ligand-binding domain 
and recognize consensus sequences known as RA response elements (RARE) which are often 
 10
present in the upstream promoter sequences of RA-responsive genes. RAR bind all-trans RA 
with high affinity and 9-cis-RA with lower affinity, whereas RXR bind 9-cis-RA only 
(Soprano et al., 2004). The effects of Vitamin A and its derivatives on gene transcription are 
presumed to be mediated largely by all-trans RA with RAR because 9-cis-RA has not been 
detected in vivo (Mic et al., 2003). 
In the absence of RA, a corepressor is bound to the RAR, preventing gene transcription via 
RAREs. When RA binds to RARs, the corepressor is released and replaced with a coactivator, 
resulting in the induction of gene transcription. These corepressors and coactivators mediate 
their effects by recruiting proteins that regulate the acetylation of histones surrounding the 
DNA that contain the RARE. Thus, RAR corepressor proteins recruit histone deacetylase 
complexes to remove the acetyle groups from the lysine residues of histones and prevent gene 
transcription. In contrast, RAR coactivator proteins recruit histone acetyl transferases to 
acetylate these lysine residues, unwind DNA and facilitate gene transcription (reviewed by 
Wei, 2003). The major corepressors are nuclear receptor corepressor (N-CoR) and silencing 
mediator for retinoid and thyroid hormone receptors (SMRT; Chen and Evans, 1995; 
Piedrafita and Pfahl, 1999). Upon binding of RA, the ligand-binding domain of the RAR 
changes shape and releases the corepressors. Coactivators are then recruited to the RAR 
(Piedrafita and Pfahl, 1999). The RA signaling cascade is summarized in Fig. 1.4. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.4: Pathways for the synthesis and mechanism of action of retinoic acid in the context 
of nerve regeneration. Modified after Mey, 2001. 
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1.6 Goals 
The molecular adjustments of cells after peripheral nerve and spinal cord lesions have been 
described in detail. Yet, the intracellular signals that regulate these processes are not 
understood as well. Recent evidence indicates that RA is involved in these processes, which 
raises the question of the physiological role of RA in the injured nervous system. 
As mentioned above RA mediates its biological activity through interaction with retinoid 
receptors, which function as transcription factors. The first aim of this work was to investigate 
their expression, intracellular distribution and differential regulation in the context of nerve 
injury. 
The cellular and molecular functions of RA are still not known in this context. Possible 
transcriptional targets of RA are cytokines that promote regeneration after nerve injury. I 
tested whether the expression patterns of injury-related cytokines and neurotrophins or the 
activation of cytokine signaling cascades were altered by RA. 
As Schwann cells are the most important modulators of Wallerian degeneration and 
subsequent regeneration in the PNS, I used Schwann cell primary cultures of newborn rats to 
investigate cellular effects of RA in vitro. In the CNS spinal cord contusion injuries were 
performed. Here, special attention was paid to neurons, because of the neurotrophic effects of 
RA, and to microglia/macrophages, because anti-inflammatory activity has been ascribed to 
RA in different contexts (Sjöberg et al., 1992). 
The experiments concerning injury-related processes after 1. peripheral and 2. central nerve 
lesions are outlined in separate chapters. Each chapter is introduced by an abstract followed 
by the particular materials and methods, results and discussion. A comparison of RA signaling 
after central and after peripheral nerve injury is made in a subsequent general discussion. 
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2 Schwann cells are targets of retinoic acid signaling 
 
2.1 Abstract 
It is likely that the transcriptional activator retinoic acid (RA) is a modulator of lesion induced 
signaling in the adult PNS. To test whether Schwann cells are targets of RA, primary cultures 
from sciatic nerves of newborn rats were investigated with Western blotting. I first showed 
that crucial components of the RA signal transduction cascade (retinoic acid receptors, 
retinoid X receptors, RALDH2, Cyp26A1, CRABP-II) occur in Schwann cells. To discover 
whether RA affects Schwann cell physiology, I then analyzed the intracellular distribution of 
RA signaling molecules via immunohistochemistry. Protein levels of retinoid receptors and 
CRABP-II were investigated after RA exposure. The spatial distribution of RXRs and 
CRABP-II changed from a cytosolic to a nuclear localization after RA treatment and CRABP-
II was downregulated by RA. To identify RA-regulated genes in Schwann cells I investigated 
the expression of trauma-related cytokines and neurotrophins with the RNase protection assay 
and tested whether RA influences their signaling pathways. The following cytokines were 
expressed by Schwann cell primary cultures: ßNGF, BDNF, GDNF, CNTF, TGFβ1, TGFβ2, 
TGFβ3, IFNβ, IFNγ and MIF. Although in various other cell culture systems unrelated to the 
nervous system RA has been reported to regulate these cytokines, I did not see any 
differential regulation by RA in Schwann cells. RA did not activate intracellular messenger 
cascades of neuropoietic cytokines or neurotrophins either. 
While my results are still in accordance with the hypothesis that Schwann cells are targets of 
RA transcriptional activity after peripheral nerve injury, the precise physiological function of 
RA in Schwann cells remains to be discovered. 
 13
2.2 Materials and methods 
2.2.1 Preparation of Schwann cell primary cultures from newborn rat sciatic nerves 
Primary cultures of Schwann cells were obtained from newborn (postnatal day 0 - 2) Sprague-
Dawley rats under sterile conditions. Rats were decapitated with scissors and immersed into 
70% ethanol for sterilization. Sciatic nerves were dissected from the dorsal side (Fig. 2.1) and 
freed from connective tissue. Nerves of six rats were combined into one petri dish (Greiner, 6 
cm ∅) containing 5 ml medium [Dulbecco´s Modified Eagle´s Medium (DMEM, Life 
Technologies) with 2 U/ml Penicillin and 2 µg/ml Streptomycin (Sigma)]. Nerves were then 
cut up into small pieces with a scalpel and the pieces were collected with a syringe into a 15 
ml tube containing 10 ml medium. After centrifugation for 5 min at 130 g the obtained pellet 
was digested for 1 h at 37°C in 5 ml DMEM containing 0.06% collagenase (Life 
Technologies) and 2.5% trypsin (Sigma). The enzymatic reaction was stopped by adding 5 ml 
DMEM containing 10% fetal calf serum (FCS, Life Technologies). Tissue was again spun 
down at 130 g for 5 min and the pellet was resuspended in 1 ml serum containing DMEM.  
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.1: Sciatic nerves were dissected after incisions through skin and muscle. 
 
To gain a single cell suspension, tissue was triturated with small gauge canules (∅ 0.7 mm 
and 0.4 mm). After final resuspension of cells in 5 ml medium and centrifugation cells were 
plated in uncoated T25-culture flasks with 5 ml serum containing DMEM. Fibroblast growth 
was reduced by adding 10 µM cytosine arabinoside (Ara C, Sigma), a cytostatic drug, after 24 
hrs for 7 days. Medium was changed every 3 days. After reaching confluency (about 3 
months) remaining fibroblasts (about 10%) had to be eliminated via a complement lysis: 
adherent cells were washed 3 times with sterile phosphate buffered saline (PBS) and then 
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trypsinated. The serum protease trypsin disrupts peptide chains of amino acid residues of L-
arginine and L-lysine. Cells were incubated for about 2 min with 1.5 ml of a 0.25% 
trypsine/EDTA-solution at 37°C and cell disruption was controlled under a microscope. 
Again, serum terminated the enzymatic reaction. The cell suspension was transferred into 8 
ml FCS containing medium and centrifuged. Pellet was resuspended in 1 ml of fibroblast-
binding monoclonal anti-mouse Thy 1.1 antibody (Sigma M7898), diluted 1/40 in PBS, and 1 
ml DMEM and incubated at 37°C for 30 min. Lyophilized baby rabbit complement (Linaris 
CL 3441), dissolved in 1 ml sterile water was added for another 30 min. Complement proteins 
bind to Thy 1.1 antibody labeled fibroblasts and induce the formation of pores in the cell 
membrane and by this lysis of the tagged cells. Lysis was blocked by adding serum containing 
medium. Pure Schwann cells were centrifuged, resuspended in 5 ml DMEM containing 10% 
FCS, 2 µM forskolin (ICN Biomedicals) and 100 µg/ml bovine pituitary extract (Invitrogen) 
and cultured in poly-L-lysine (Sigma) coated (200µg/ml in sterile water) T25-culture dishes. 
Confluent Schwann cells were expanded on poly-L-lysine coated T75-culture dishes with 
DMEM containing 10% FCS and 2 µM forskolin. Forskolin activates the adenylyl cyclase, 
thus raises the level of cyclic adenosine mono-phosphate (cAMP). During experiments cells 
were kept in medium without forskolin 24 hrs before RA treatment. Confirmation of Schwann 
cell identity was given by immunohistochemical staining with the S-100 antibody (Sigma). 
 
2.2.2 Western blotting 
For immunoblotting Schwann cells were treated with of 1, 10 and 100 nM all-trans RA 
(Sigma). In all experiments RA was diluted in dimethyl sulfoxide (DMSO, Sigma) and 
applied in 10 µl of a 1000-fold stock solution to 10 ml culture medium. Only final 
concentrations are mentioned below. Cells treated only with DMSO (also 10 µl in 10 ml 
medium) served as control. After 24 hrs and 48 hrs cells were trypsinized and the pellet was 
washed with PBS to remove serum constituents. Schwann cells were triturated in 50 µl 
hypotonic buffer (20 mM HEPES, pH 4.4) containing 1% Triton X-100 (Serva) for break-
down of cell membranes, and protease inhibitors 1 mM PMSF (Serva), 1 µM leupeptin 
(Sigma), 1% aprotinin (Sigma). They were kept on ice for one hour and after 20 min 
centrifugation at 12,000 g at 4°C the content of soluble protein extracts was measured by 
bicinchoninic acid protein assay kit (BCA, Sigma). In this test alkaline Cu(II) is reduced to 
Cu(I) by proteins depending on their concentration. Cu(I) forms a purple complex with 
bicinchoninic acid with a maximum of absorbance at 562 nm. The extinction at 562 nm is 
proportional to the protein concentration. With bovine serum albumin (BSA, Serva) protein 
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standards were generated of 0.1, 0.2, 0.4, 0.8, 1.4, 2.0 and 3.2 µg/µl. Schwann cell extracts 
were diluted 1/10 in hypotonic buffer and to every sample/standard 500 µl of 1x 4% Cu2SO4 
(Sigma) and 50x BCA were added. After incubation at 37°C for 30 min extinction was 
measured with the ELISA-reader (Bio-Tec Instruments) at 630 nm. Protein amounts were 
calculated by linear regression of measured extinctions of protein standards. The test was 
performed to apply equal amounts of protein concentrations in the subsequent gel 
electrophoresis. 
Proteins were separated with SDS-PAGE (sodium dodecyl sulfate – polyacrylamide gel 
electrophoresis) according to their size under denaturating conditions (Mini-Protean 3 Cell, 
BIO-RAD). A discontinuous buffer system was used, where gel and electrode reservoirs 
contained different buffer ions. With use of two different gel systems the compression of 
protein samples in a thin starting band at the end of the stacking gel followed by fine 
separation within the resolving gel was achieved. The 12% resolving gel [2.5 ml 1.5 mM Tris-
HCl pH 8.8, 4.0 ml acrylamide/bis (30% T, 2.67% C, Sigma), 3.5 ml aqua dest., 100 µl SDS 
(10%, Serva), 60 µl ammoniumpersulfate (APS, 10%, Serva), 5 µl TEMED, (VWR)] and 
afterwards the 5% stacking gel [1.2 ml 0.5 mM Tris-HCl pH 6.8, 0.5 ml acrylamide/bis (30% 
T, 2.67% C), 3.3 ml aqua dest., 50 µl SDS (10%), 30 µl APS (10%), 10 µl TEMED] 
polymerized 1 h each. Before the gel was loaded with protein samples and molecular weight 
standards (Precision Plus ProteinTM, BIO-RAD), the samples were denaturated by heating for 
3 min with 2% SDS and 5% 2-mercaptoethanol. Electrophoresis lasted at 15 mA/gel about 1 h 
in the stacking gel and with 30 mA/gel about 45 min in the resolving gel. Electrophoresis 
buffer (pH 8.3) contained 25 mM Tris, 192 mM glycine and 0.1% SDS. 
To expose separated proteins to antibody labeling, they were transferred onto a nitrocellulose 
(NC) membrane by tank blotting. The transfer occurred in a gel cassette (Mini Trans-Blot 
electrophoretic transfer cell, BIO-RAD) in transfer buffer (25 mM tris, 192 mM glycine, pH 
8.3) at a power of 35 W for 2 hrs or 4 W overnight. The protein transfer was checked by 
incubation with Ponceau-S solution (3% Ponceau-S, 30% TCA, 30% sulfosalicilic acid) for 5 
min at room temperature (RT). 
For antibody staining of the blotted proteins an enhanced chemiluminiscence reaction was 
performed (ECL; Amersham). ECL is a light emitting, non-radioactive method for the 
detection of immobilized specific antigens with horseradish peroxidase (HRP) labeled 
antibodies. Chemical excitation is the effect of HRP catalyzed oxidation of luminol under 
alcaline conditions and the presence of chemical enhancers such as phenols. The maximum 
light emission occurs at a wavelength of 428 nm and can be detected with X-ray films. 
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Non-specific binding sites were blocked with 10% BSA in Tris buffered saline/Tween 20 
buffer (TBS-T; 20 mM Tris, 0.8% NaCl, 0.1% Tween 20, pH 7.6) for 10 min (polyclonal 
antibody) or 1 h (monoclonal antibody) at RT on a laboratory shaker. Then, the NC 
membrane was washed 3 times in TBS-T for 15 sec. The following primary antibodies were 
used: polyclonal rabbit serum anti RARα (dilution 1/500, Santa Cruz sc-551), RARβ (1/500, 
sc-552), RXRα (1/500, sc-553), RXRβ (1/500, sc-831) and RXRγ (1/500, sc-555) as well as 
mouse monoclonal anti RARγ (sc-7387) and CRABP-I (1/1000, Affinity BioReagents, MA3-
813). The CRABP-II monoclonal antibody (1/1000) was kindly provided by Pierre Chambon, 
Strasbourg. RALDH-2 (gift from Peter McCaffery, Boston) and Cyp26A1 (Alpha Diagnostic) 
were detected with a rabbit antiserum (1/2000). All antibodies were diluted in TBS-T/1% 
normal goat serum (NGS, Sigma). Incubation was done 1 h at RT on a rocker. After washing 
3 times short and once for 10 min with TBS-T, NC membrane was incubated for 15 min with 
peroxidase conjugated secondary antibodies goat anti-rabbit IgG (1/5000) and goat anti-
mouse IgG (1/10000, Sigma A6154, A3682). Secondary antibodies were diluted in TBS-T 
plus 5 % gelatine (Amersham). The washing procedure was repeated and immunoreactivity 
was detected via ECL (equal volumes of detection solutions from ECL kit), exposure on an 
X-ray film (Hyperfilm ECL) for 1 to 30 min (depending on the intensity of the signal) and use 
of digital image analysis system (LTF) to measure the optical density of protein bands. For 
statistics logarithms of immunoreactivity values were analyzed with ANOVA and post-hoc 
Dunnett´s test. 
 
2.2.3 Determination of protein distribution 
For immunofluorescence staining Schwann cells were subcultured in 24-well-plates on poly-
L-lysine coated glass cover slips (VWR). After reaching confluency they were treated with 10 
nM all-trans-RA or with DMSO for 5, 15, 30, 60 min and 19 hrs. Afterwards, the culture 
medium was removed and cells were fixed in 1 ml/well of 4% para-formaldehyde (PFA, 
Fluka) for 15 min and washed with TBS 3 times for 5 min. To avoid background staining 
cells were blocked for 90 min with 300 µl/well of 2% normal goat serum NGS in TBS and 
0,4% Triton X-100 for permeabilization. Schwann cells were incubated overnight at 4°C with 
primary antibodies (300 µl/well) against RALDH-2, Cyp26A1 (1/200), CRABP-I and -II 
(1/1000), RARα, β, γ and RXRα, β, γ (1/100), also diluted in 1% NGS and 0,04% Triton X-
100. After three washes in TBS (5 min each), cells were incubated for 60 min with 300 
µl/well of Alexa FlourTM 546 goat anti rabbit (1/1000) and goat anti mouse (1/2000) IgGs 
(MoBiTec). Following three washes with TBS (5 min each), Schwann cell covered slips were 
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embedded upside down in Fluoprep (Merieux) on a slide. Cells were analyzed by 
fluorescence microscopy using a Zeiss axiophot fluorescent microscope (20x objective for 
cell counting and 100x objective for pictures). Pictures were made with Zeiss Axiovision 
software. For quantitative categorization according to the intracellular localization of the 
immunoreactive signal Schwann cells were counted and divided into one of five groups of 
“only nuclear staining”, “more nuclear staining”, “equal staining ”, “more cytosolic staining”, 
and “only cytosolic staining”. Examples for each group are illustrated in Fig. 2.2. 300 cells 
were counted in three independent cultures for each time point and each antibody against 
CRABP-II, RARα, β, γ and RXRα, β, γ. 
 
 
Fig. 2.2: Intracellular localization of immunoreactivity. a: only nuclear staining; b: more 
nuclear staining; c: equal staining; d: more cytosolic staining; e: only cytosolic staining. 
 
2.2.4 RNase Protection Assay (RPA, RiboQuantTM, BD PharMingen) 
Deprived Schwann cell primary cultures were treated with 1000, 100, 10 and 1 µM all-trans 
RA. In an additional experiment these concentrations were combined with 1 µM trichostatin 
A (Cayman Chemical) dissolved in DMSO. For detection of cytokine-cytokine interactions 
Schwann cells were treated with 100 U/ml IL-1β, 200 U/ml IL-6 (gifts from Institut für 
Biochemie, Klinikum Aachen) or 20 ng/ml CNTF (gift from Michael Sendtner), all dissolved 
in DMEM and administered from 100x stock solutions. Untreated Schwann cells served as 
control. After 24 h, 48 h, 96 h cells of two culture flasks were harvested as described for 
western blotting and pellets were pooled to generate one sample. RNA was isolated using 
Trizol (Invitrogen) based on the method of Chomszynski and Sacchi, 1987: every sample was 
homogenized with 0.5 ml Trizol reagent (phenol-guanidine isocyanate) and incubated for 5 
min at RT to dissociate the nucleo-protein complex (all work had to be done under the fume 
hood). 0.1 ml chloroform (Sigma) was added, shaken for 15 sec and incubated for 3 min. 
Samples were centrifuged at 4°C for 15 min at 12000 g to separate RNA from genomic DNA. 
The upper aqueous RNA-containing phase was transferred into 0.25 ml isopropanol for 30 
min on ice to precipitate RNA and 5 µl of glycogen were added for pellet visualization after 
centrifugation for 20 min at 4°C at 12000 g. The pellet was washed with 0.5 ml ice-cold 75% 
ethanol and after additional centrifugation at 7500 g for 5 min the RNA pellet was air-dried 
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and re-dissolved in 40 µl diethyl-pyrocarbonat (DEPC, Sigma) treated water. Before freezing 
RNA was heated for 10 min at 55°C. To estimate the RNA content in the sample the 
extinction of the RNA sample was measured photometrically (Hitachi) at 260 nm (OD260) 
after 1/100 dilution of extracted RNA. The concentration of total RNA [µg/ml] was calculated 
as follows: OD260 x 40 µg/ml x 100 (dilution 1/100).  
The subsequent ribonuclease protection assay was performed in the university´s radiation 
safety because of the use of the nuclid P33 ([α33P]UTP, Hartmann Analytic, SCF-210, 110 
TBq/mmol, 3000 Ci/mmol). The RNase protection assay (RPA) is a highly sensitive and 
specific method for the detection and simultaneous quantification of several mRNA species in 
a single sample of total RNA. Template sets contain linearized plasmid DNA templates, each 
of which represents a single RNA-species, possesses a specific size and can be used for the T7 
RNA polymerase-directed synthesis of [α33P]-labeled anti-sense probes. Probes hybridized 
with target mRNA encoding βNGF, BDNF, GDNF, CNTF, NT-3 and NT-4 (rNT, Cat. # 
45028P) and IFNβ, TNFβ, GM-CSF, TGFβ1, TGFβ3, TGFβ2, Ltβ, TNFα, MIF and IFNγ 
(rCK-1, Cat. # 45027P), and two housekeeping gene products, L32 ribosomal protein and 
glycerinaldehyde-3-phosphate dehydrogenase (GAPDH). Housekeeping genes are expressed 
in almost every cell type and encode for constantly used proteins. The RPA protocol 
according to the instruction manual of the RiboQuantTM In Vitro Transcription Kit 
(Pharmingen) is briefly described below: 
For synthesis of radioactive labeled RNA antisense-probes via T7 RNA Polymerase the 
following substances were used: a template set (containing plasmid DNA fragments under 
control of the T7 bacteriophage promoter), RNasin protease for digestion of RNases, GACU 
(nucleotids for RNA generation), dithiothreitol for reduction of proteins and radioactive 
[α33P]UTP. The reaction was terminated after 1 h by adding template digesting DNase for 30 
min. Spared probes were purified via phenol/chloroform-isoamyl alcohol and precipitated 
with ammonium acetate and 100% ethanol at –70°C for 30 min. Antisense probes were 
hybridized with target mRNA in hybridization buffer overnight. On the following day non-
hybridized probes and other single-stranded RNA were digested adding RNase A which was 
inhibited after 45 min via proteinase K for 15 min. Protected hybrids were again purified and 
precipitated at –70°C for 30 min and separated via electrophoresis on a denaturing 5% 
polyacrylamide gel. Probes of housekeeping genes (L32, GAPDH) were used to compare the 
levels of individual mRNA species between samples and served as control for integrity of the 
RNA in the RPA procedure. Dilutions (1/10, 1/100) of the probe set were used as size 
markers. These unprotected probe bands migrate slower than their appropriate protected 
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bands, e.g. the unprotected probe of βNGF has a nucleotide size of 351 and that of the 
protected probe is 322 (see table 2.1). This is due to flanking sequences in the (unprotected) 
probe that are not protected by mRNA. Samples of rat control RNA and yeast tRNA served as 
positive and negative control, respectively. Gel was dried in a gel dryer (BIO-RAD) under 
vacuum for 1.5 hrs at 75°C and was then exposed to an X-ray film in an autoradiography 
cassette for at least three days at –70°C. 
 
Table 2.1: Templates with corresponding unprotected and protected nucleotide (nt) sizes. 
template unprotected 
probe (nt) 
protected probe 
(nt) 
template unprotected 
probe (nt) 
protected probe 
(nt) 
βNGF 351 322 TGFβ1 285 256 
BDNF 315 286 TGFβ3 255 226 
GDNF 282 253 TGFβ2 231 202 
CNTF 255 226 Ltβ 210 181 
NT-3 231 202 TNFα 189 160 
NT-4 213 184 MIF 171 142 
IFNβ 390 361 IFNγ 158 127 
TNFβ 351 322 L32 141 112 
GM-CSF 324 295 GAPDH 126 97 
 
 
2.2.5 Cytokine treatment 
Deprived Schwann cell primary cultures were treated with 10 nM all-trans RA for 3 h, 6 h, 12 
h, 24 h and 48 h for cytokine treatment; for neurotrophin treatment 48 h. Medium was 
changed and neuropoietic cytokines [20 ng/ml CNTF, 200 U/ml IL-6 or IL-6 plus soluble IL-
6 receptor α-subunit (1 µg/ml; gifts from Institut für Biochemie, Klinikum Aachen)] or 
neurotrophins [20 ng/ml NGF (Sigma, N8133) or 20 ng/ml BDNF (Sigma, B3795)] were 
added for 30 min. 
After protein isolation, discontinuous SDS-PAGE and Western blot (see 2.3.2) 
phosphorylated and unphosphorylated Stat3 or Erk1/Erk2, respectively, were detected with 
rabbit antisera, diluted 1/1000 (Stat3: #S21320, Transduction Laboratories; Phospho-Stat3: 
#9131, polyclonal p44/42 MAP Kinase: #9102 and polyPhospho-p44/42 MAP Kinase: #9101, 
Cell signaling technology). Peroxidase-conjugated secondary antibodies goat anti-rabbit IgG 
were diluted 1/5000. Immunoreactivity was recorded with ECL and compared in RA-treated 
and untreated Schwann cells. The best way of confirming equal amounts of applied protein is 
stripping (complete removal of primary and secondary antibodies from the membrane) after 
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antibody staining against phospho Stat3 and phospho Erk1/Erk2 and reprobing membranes 
with antibodies against unphosphorylated Stat3 or Erk1/Erk2. According to the 
manufacturer´s protocol membranes should be stored wet-wrapped in a refrigerator after each 
immunodetection and stripped before re-use. In my experience immunoreactivity after 
stripping was much weaker than without, so I decided to use a different membrane for 
antibody staining against Stat3 and Erk1/Erk2. Later, after I had completed these experiments, 
we found out that signals can be improved by stripping membranes immediately after 
finishing the immunodetection protocol. 
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2.3 Results 
2.3.1 Molecules of the retinoic acid signaling cascade are present in Schwann cell primary 
cultures of newborn rats 
To address the question whether Schwann cells are targets of RA signaling in the PNS, 
Western blots were performed in Schwann cell primary cultures, established from sciatic 
nerves of newborn rats. Results showed that all components of the RA signaling cascade 
except CRABP-I were present in Schwann cells (Fig. 2.3). Cell extracts contained cytosolic, 
nuclear and membrane-bound proteins. All retinoic acid receptors showed one band each with 
a molecular weight of 37 kDa for RARα, 55 kDa for RARβ and 50 kDa for RARγ. 
Immunoreactive bands of RXRα had a size of 83 and 46 kDa, that of RXRβ 38 kDa and those 
of RXRγ a size of 55 kDa and 47 kDa. Immunoreactivity against the RA-synthesizing enzyme 
RALDH2 resulted in one predominant band at 55 kDa and the RA-degrading enzyme 
Cyp26A1 showed one band of 51 kDa. Of the cellular retinoic acid binding proteins only 
CRABPII was detected, it had a molecular weight of 20 kDa. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.3: Expression of retinoic acid signaling molecules in Schwann cells. 
All components of the RA signaling cascade except CRABP-I are present in Schwann cells. 
M: molecular weight of standards. Top down: β-galactosidase, phosphorylase b, bovine 
serum albumin, glutamic acid dehydrogenase, lactate dehydrogenase, carbonic anhydrase, 
trypsin inhibitor. 
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2.3.2 RA treatment induces translocation of retinoid X receptors and CRABP-II into the 
nucleus 
Retinoid receptors are thought to reside exclusively in the cell nucleus (Chambon, 1996), 
where they bind to the DNA and facilitate gene transcription. Recent studies suggested that 
although RAR and RXR are concentrated in cell nuclei, they can shuttle between the nucleus 
and cytoplasm like other nuclear receptors (Katagiri et al., 2000; Mackem et al., 2001). The 
regulation of subcellular localization might represent a new way in which retinoid receptors, 
and other nuclear receptors, can affect cellular function (Lane and Bailey, 2005). To 
investigate whether RA induces a nuclear shift of its signaling molecules their intracellular 
distribution was investigated via immunocytochemistry in untreated versus RA-treated cells. 
Immunofluorescence microscopy of untreated cells showed a predominantly cytosolic 
location of the RARs with an intense signal for RARα  that was distributed in the entire 
cytoplasm and weaker signals for RARβ and RARγ, concentrated in the cytosol in the vicinity 
of the nucleus (Fig. 2.4). RXRα and γ also displayed a cytoplasmatic staining close to the 
nucleus, while RXRβ was more prominent within the cell nucleus, where small stained 
nuclear foci were visible. Immunoreactivity of CRABP-II, which is assumed to facilitate the 
nuclear translocation of RA (Budhu and Noy, 2002; Dong et al., 1999), the cytosolic enzyme 
RALDH2 and the RA- degrading enzyme Cyp26A1, which has been reported in the 
endoplasmatic reticulum, were also found to be almost exclusively in the cytosol. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.4: In untreated Schwann cells the intracellular localization of all components of the 
RA signaling cascade except RXRβ is predominantly cytosolic. Scale bar: 10 µm, same 
magnification in all photographs. 
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Exposure to RA caused a partial translocation of its binding proteins and receptors from the 
cytoplasm into the nucleus: Schwann cells were treated for 5, 15, 30, 60 minutes and 19 h 
with 10 nM all-trans RA, fixed and immunostained. Every cell was then assigned to one of 
five groups of “only nuclear staining”, “more nuclear staining”, “equal staining”, “more 
cytosolic staining” or “only cytosolic staining” according to its particular immunoreactive 
signal. This evaluation demonstrated that all retinoid X receptors started to shift into the 
nucleus after 15 to 30 minutes, reaching a maximum after 19 hours of RA treatment (Fig. 
2.5). 
 
 
Fig. 2.5: Quantitative analysis of the intracellular distribution of retinoid receptors and 
binding proteins after RA administration. After treatment of 5, 15, 30, 60 minutes and 19 h 
with 10 nM all-trans RA compared to untreated cells retinoid receptor and CRABP-II 
distribution was classified into one of five groups of “only nuclear staining”(only C), “more 
nuclear staining”(C < N), “equal staining ” (C = N), “more cytosolic staining”(C > N) or 
“only cytosolic staining” (only N); n = 300 cells counted in three repetitions for each time 
point and antibody. 
 
The strongest effects were seen for RXRβ: without RA administration 20 % of all counted 
cells exhibited a more cytosolic staining and in almost 50 % of cells the signal was equal in 
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cytoplasm and nucleus; 30 % showed a more nuclear staining. After 19 h 20 % of counted 
cells exhibited an equal staining of cytoplasm and nucleus and 80 % a more nuclear signal. 
CRABP-II was located almost exclusively in the cytoplasm in untreated cells. After RA 
treatment it migrated into the nucleus with a maximum after 15 minutes, while after 30 
minutes it was again predominantly in the cytoplasm. Typical immunoreactivity data are 
illustrated in Fig 2.6. 
 
Fig. 2.6: Nuclear translocation of retinoid X receptors and CRABP-II. Without RA all 
molecules displayed a stronger cytoplasmatic signal. After 15 min RXRs started to move into 
the nucleus with a maximum at 19 h. CRABP-II showed the strongest nuclear signal after 15 
min of RA administration and was after 19 h again almost exclusively in the cytoplasm. Scale 
bar: 10 µm, same magnification in all photographs. 
 
Contrary to expectations no changes in the intracellular distribution over time were visible for 
any of the retinoic acid receptors. Despite their role as ligand-activated transcription factors, 
RARs always displayed a stronger signal in the cytosol compared to the nucleus (Fig. 2.7). 
Cyp26A1 and RALDH-2, as expected, were always found exclusively in the cytosol (data not 
shown). 
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Fig. 2.7: At all times of RA exposure RARs were distributed mostly in the cytosol. n = 300 
cells counted in three independent cultures for each time point and antibody. 
 
2.3.3 Autoregulatory functions of retinoid signal transduction in Schwann cells 
As a transcriptional activator RA may not only act on other cells but also in an autocrine 
manner to influence its own signaling cascade via positive or negative regulation of the 
amount of available signaling molecules. To investigate this, Schwann cell primary cultures 
were treated with varying doses of all-trans RA (1, 10, 100 nM) for 24 and 48 hrs. Then, the 
protein contents of retinoid receptors and CRABP-II in the cultures were quantified (Figs. 2.8, 
2.9). Neither RAR- nor RXR- protein concentrations were altered by RA, while the 
expression of CRABP-II was downregulated after 24 and 48 hrs by RA with all used 
concentrations (Fig. 2.8). The quantification of CRABP-II reduction is illustrated in Fig. 2.9: 
compared to DMSO-treated Schwann cells the concentration of CRABP-II was diminished to 
63%. 
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Fig. 2.8: Retinoid receptor- and CRABP-II protein expression after RA application. RA had 
no influence on RARs and RXRs. CRABP-II expression was reduced after 24 and 48 hrs of RA 
treatment. 
 
This effect was significant for 1 nM RA treatment for 24 h 10 and 100 nM RA for 48 h. The 
downregulation of CRABP-II points to a negative feedback mechanism with a diminished 
expression of RA binding protein in case of RA overdose. CRABP-II serves to transport RA 
from the cytosol to the nucleus and by this mechanism enhances the transcriptional activity of 
RA (Budhu and Noy, 2002). 
 
 
Fig. 2.9: Quantitative analysis of CRABP-II protein expression after RA application. 
Control cells received DMSO. (n = 7 in all experiments, error bars indicate SEM; * p < 0.05, 
** p < 0.01). 
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2.3.4 Cytokine expression in Schwann cells 
From the RA-effect on intracellular distribution of RXRs and CRABP-II and from 
observations after sciatic nerve injury in vivo (Zhelyaznik et al., 2003) I expected that RA 
would regulate the expression of lesion-induced genes in Schwann cells. Since neuropoietic 
cytokines or neurotrophins serve as mediators in neuroglial interactions and are differentially 
regulated after peripheral nerve injury, I investigated whether their expression in Schwann 
cells was altered by RA. Therefore Schwann cells were treated with 1, 10 and 100 nM all-
trans RA for 24 h, 48 h and 96 h. I investigated their cytokine expression with ribonuclease 
protection assay. The RNase protection assay (RPA) is a highly sensitive and specific method 
for the simultaneous detection and quantification of several gene transcripts out of one mRNA 
extract. The results showed that ßNGF, BDNF, GDNF, CNTF, TGFβ1, TGFβ2, TGFβ3, 
IFNβ, IFNγ and MIF were expressed in Schwann cell primary cultures, while the following 
cytokine transcripts could not be detected: NT3, NT4, TNFα, TNFβ, GM-CSF and Ltβ (Figs. 
2.10, 2.11). While unprotected probe bands migrated slower than their corresponding 
protected bands of target mRNA, the identity of every protected band can clearly be 
determined due to the its own spatial position and nucleotide size and those of unprotected 
probes (outlined in table 2.1). After RA-treatment of 24, 48 and 96 hrs no differential 
regulation of these cytokines was visible. Experiments were done for neurotrophins: 24h, n = 
4; 48 h, n = 2; 96 h, n = 1; for cytokines: 24 h, n = 1; 48 h, n = 1; 96 h, n = 1. IFNβ  is 
expressed in Schwann cells as demonstrated in Fig. 2.11, but on a very low level. 
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Fig. 2.10: RNase protection assay (RPA) for neurotrophins (left) and cytokines (right). 
Schwann cell primary cultures were treated with all-trans RA 48 h in vitro. Control cells 
received DMSO. Dilutions of the probe set were used as size markers. Rat control RNA served 
as positive-, yeast tRNA as negative control. 
 
Trichostatin, an inhibitor of the histonedeacetylase, is known to potentiate transcriptional 
activity of RA. It selectively inhibits the removal of acetyl groups from the amino-terminal 
lysine residues of core histones. This facilitates the access of transcription factors to the 
underlying genomic DNA (reviewed by Wei, 2003). To see whether possible effects of RA 
might be revealed with the histone deacetylase inhibitor, additional experiments with RA plus 
1 µM Trichostatin A were performed. Again, no regulatory effect of RA was observed with 
the RNase protection assay. TGFβ2 seemed to be slightly upregulated by Trichostatin A. This 
effect was independent of RA as it occured also in cells treated with DMSO plus Trichostatin 
A. 
Schwann cells were then treated with IL-1β (100 U/ml), IL-6 (200 U/ml) or CNTF (20 
nM/ml) to investigate whether cytokines influence their own gene expression. No changes in 
cytokine expression occurred compared to DMSO treated cells (Fig. 2.11). Experiments were 
done for 24 hrs and 48 hrs of cytokine exposure, but no effect was observed. 
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Fig. 2.11: RPA: neither RA plus Trichostatin A (T; left) nor cytokine treatment (right) 
induced changes in cytokine expression in Schwann cells. *: bands, which could not be 
related to one of the templates used. 
 
2.3.5 Molecular mechanisms of RA-/cytokine interactions in Schwann cells 
Since the hypothesis of RA-dependent regulation of cytokine expression in Schwann cells 
was not confirmed with the RPA experiments, I decided to investigate whether RA plays a 
role downstream in the signaling cascade of trauma-related neuropoietic cytokines and 
neurotophins. Such crosstalk had been reported for RA activation of the Erk pathway in 
mouse embryonic stem cells (Bost et al., 2002). Therefore synergistic effects of RA and 
cytokines on the activation of intracellular second messenger cascades were investigated. As 
already described (see 1.2) binding of neuropoietic cytokines to their appropriate receptor 
leads to dimerization of receptor subunits, activation of Janus kinases (Jaks), which in turn 
phosphorylate the cytoplasmatic part of the gp130 receptor subunit. Thereby, binding sites for 
Stat (signal transducer and activator of transcription) factors (Stat1 and Stat3) are exposed, 
become phosphorylated by Jaks, dimerize, translocate into the nucleus and act as transcription 
factors. Receptors of neurotrophins form dimers after ligand binding and are 
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autophosphorylated via an intracellular kinase domain. This activates several intracellular 
signal transduction pathways, including the Ras/Raf cascade, which leads to phosphorylation 
of the MAP kinase (mitogen-activated protein kinase, MAPK) that in turn activates further 
transcription factors. Thus the status of phosphorylation of Stat factors and MAP kinase is 
indicative of gene activation by neuropoietic cytokines or neurotrophins. 
I treated Schwann cell primary cultures for 3 h, 6 h, 12 h, 24 h and 48 h with 10 nM RA and, 
after change of medium (to exclude cytokine induction via RA), with CNTF (20 ng/ml), IL-6 
(200 U/ml) and IL-6 plus soluble gp80, the IL-6 receptor subunit (1 µg/ml) for 30 min. Most 
extracellular signals typically activate signal transduction pathway within 30 min, and a 
change in phosphorylation status can be observed. Adding of soluble gp80 normally prevents 
IL-6 binding to endogenous gp80 and subsequent Stat-activation. As expected, Schwann cells 
treated without cytokine did not show any Stat3 phosphorylation. Since the medium was 
changed before cytokine treatment the effect of endogenous RA-induced cytokines can be 
excluded and therefore no Stat3 phosphorylation was expected. IL-6 and CNTF treatment did 
not induce phosphorylation of Stat3, neither in DMSO treated control cells nor in combination 
with RA. Application of IL-6 plus soluble IL-6 receptor subunit in contrast resulted in Stat3 
phosphorylation. This seems to be due to binding of gp80-bound IL-6 to the gp130 subunit 
which forms the functional IL-6 receptor complex. It seems also that the gp80 subunit, as well 
as LIFR subunit (needed for CNTF binding together with CNTFR subunit, which is known to 
be expressed in Schwann cell primary cultures) are not expressed on the surface of Schwann 
cells as neither IL-6 alone nor CNTF induce a phosphorylation of Stat3. No regulation was 
seen after RA treatment at any measured time point (Fig. 2.12). Stat3 staining was also not 
altered by RA, which indicates that RA does not regulate Stat3 expression. 
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Fig. 2.12: Stat3 phosphorylation in Schwann cells 3, 6, 12, 24 and 48 h after cytokine and 
RA treatment. Antibody staining against phospho-Stat3 and Stat3 showed bands of 92 kDa. 
Stat3 staining indicates equal amounts of Stat3 protein in the samples. 
 
To check the influence of RA on signal transduction of neurotrophins, Schwann cells were 
treated for 48 h with 10 nM RA and NGF (20 ng/ml) or BDNF (20 ng/ml) simultaneously and 
the activation of MAP kinases extracellular-signal-regulated kinases (Erk)1 and Erk2 was 
investigated. I found an endogenous phosphorylation of Erk1/2 after DMSO or RA treatment 
without neurotrophin application. This effect [which is also mentioned in the literature (Zheng 
et al., 1996)] might be caused by neurotrophins contained in the FCS within the medium or be 
due to a release of pre-secreted neurotrophins by Schwann cells themselves, stimulated e.g. by 
medium change. As mentioned before, NGF and BDNF were expressed in these cultures (Fig. 
2.10). Other cytokines also converge on the Ras/Raf-MAPK-pathways. To minimize 
influences of medium, experiments were repeated with DMEM containing 2 µM forskolin 
instead of FCS. Again, an endogenous Erk1/2 phosphorylation occurred pointing to a 
neurotrophin secretion of Schwann cells. In FCS-containing medium the phosphorylation 
level was reduced by NGF and also slightly by BDNF, indicating a negative feedback-
inhibition in case of neurotrophin excess. No regulatory difference between DMSO treated 
and RA treated Schwann cells occurred (Fig. 2.13). Total Erk1/2 levels were unchanged by 
RA treatment, equal amounts of protein were loaded. 
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Fig. 2.13: Phosphorylation of Erk1 (phospho-p42 MAPK) and Erk2 (phospho-p44MAPK) 
in Schwann cells after treatment with RA and neurotrophins. Antibody staining against 
phospho-Erk1 and Erk1 showed bands of 42 kDa, against phospho-Erk2 and Erk2 of 44 kDa. 
Schwann cells were deprivated in DMEM containing 10 % FCS or 2 µM forskolin. 
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2.4 Discussion 
2.4.1 Intracellular (trans-)location of RA signaling components 
It has been suggested that RA participates in the physiological processes after nerve injury. In 
this work I investigated whether Schwann cells are putative targets of RA in the PNS. With 
Western blotting I found that all components of RA signaling except cellular retinoic acid 
binding protein (CRABP)-I were present in Schwann cells. This finding is in agreement with 
data of sciatic nerves where CRABP-I gene transcripts but not protein expression were 
detected (Zhelyaznik et al., 2003; Schrage, 2001). Immunofluorescence microscopy showed a 
predominantly cytosolic location of retinaldehyde dehydrogenase RALDH2, the RA-
degrading enzyme CYP26A1, the retinoid receptors RARα, β, γ, RXRα, γ, and CRABP-II. In 
contrast, RXRβ was more concentrated in the cell nucleus. After RA treatment all retinoid X 
receptors showed a nuclear shift after 15 to 30 minutes, reaching a maximum after 19 hours. 
The strongest effects were seen for RXRβ. CRABP-II migrated into the nucleus with a 
maximum at 15 minutes, but after 30 minutes CRABP-II was again localized predominantly 
in the cytoplasm. No change in the intracellular distribution was visible for any of the retinoic 
acid receptors. Studies of the subcellular localization of CRABP-II revealed that it is cytosolic 
in the absence of its ligand and that it translocates into the nucleus upon treatment with RA. 
CRABP-II interacts with RAR in a ligand-dependent fashion forming a short-lived 
intermediate complex (Dong et al., 1999) that facilitates RA channeling to the receptor and by 
this enhances the transcriptional activity of RA, especially when cellular levels of either RA 
or RAR are limiting (Budhu and Noy, 2002). It was also shown that CRABP-II binds RARα 
and RXRα also in a ligand independent manner in mammalian cells (Bastie et al., 2001). 
CRABP-II mediates its nuclear localization by using a nuclear localization sequence (NLS) 
manifested in its folded state. It does not possess an NLS in its primary structure which 
normally serve as signature for subcellular targeting (Sessler and Noy, 2004). Thus, CRABP-
II appears to be a transcriptional regulator involved in RA signaling. 
In contrast, retinoid receptors are thought to be localized exclusively in cell nuclei, working as 
ligand activated transcription factors. However, in Schwann cell primary cultures RARs 
always displayed a stronger signal in the cytosol compared to the nucleus. Recent studies 
suggested that RARs can shuttle between the nucleus and cytoplasm like other nuclear 
receptors. This was shown using chimeras consisting of RAR and glucocorticoid receptors 
(Mackem et al., 2001). Similarly, Maruvada and others demonstrated that approximately 20 % 
of RAR-green fluorescent protein (GFP) chimeras were cytosolic but moved rapidly to the 
nucleus on binding all-trans-RA (Maruvada et al., 2003). In vitamin A-deficient rats, the 
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RARα subcellular localization in germ cells changed from mainly nuclear to more 
cytoplasmatic following retinol depletion (Akmal et al., 1998). In accordance with these 
findings Braun and others (2002) discovered that RA induced the nuclear translocation of 
RARα within 30 min in mouse Sertoli cell lines and that long term exposure increased 
transcription of the receptor gene resulting in increased RARα protein levels. These findings 
are in agreement with the predominant cytosolic location of RARs found in untreated cells. 
The observation that in my experiments receptors were never found exclusively in the nucleus 
and that even after RA treatment no nuclear shift was detectable might be explained as 
follows: 1. The translocation of RARs constitutes a regulatory mechanism for RA-facilitated 
gene transcription. This would be prevented through cytosolic location of RARs. Forskolin, 
contained in the cell culture medium, activates the cAMP-dependent protein kinase (PKA) via 
activating the adenylyl cyclase and elevating the cAMP level. It might be one factor that 
provokes the cytoplasmatic location of RARs even after RA application. Dibutyryl cAMP and 
follicle stimulating hormone inhibit the nuclear localization of RARα (Braun et al., 2002; Hu 
and Gudas, 1990; Xiao et al., 1996). However, in Schwann cells it was recently shown that 
forskolin had no direct influence on the localization of retinoid receptors (Weßels, 2005). 2. 
Although RAR displayed a more cytosolic signal, there was always a substantial proportion 
located in the nucleus. This proportion may be sufficient to mediate gene transcription 
forming heterodimers with translocating RXRs. As I found transcriptional activity after RA 
treatment, namely the downregulation of CRABP-II, this explanation is more likely. 
A regulation of nuclear localization for RXRs, as observed for RXRα, -β, and -γ in Schwann 
cells has also been shown by others in different cell culture systems: NGF induced the 
phosphorylation of Ser 105 of the orphan receptor NGFI-B in PC12 cells. Using nuclear 
export signals within NGFI-B this resulted in a translocation of the NGFI-B:RXR heterodimer 
complex out of the nucleus and lead to a reduced transcriptional activity of RXR:RAR 
heterodimers (Katagiri et al., 2000b). The trafficking of ligand-bound retinoid receptors to the 
nucleus, where they can induce gene expression, represents a new way in which RAR and 
RXR can affect cellular function. The time course of receptor translocation with a maximum 
at 19 h and of CRABP-II within 15 min indicates that RA increases CRABP-II-facilitated 
receptor nuclear localization followed by de novo protein synthesis of RXRs, as thereafter 
CRABP-II is found mainly in the cytoplasm. In Sertoli cells such a positive feedback loop for 
RARα is suggested in the presence of RA. RA triggers a relatively rapid nuclear localization 
of RARα, leading to enhanced transcriptional activity of RARα, and this in turn causes 
increased expression of endogenous RARα (Braun et al., 2000). After retinol injection into 
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vitamin A-deficient rats the RARα protein level was elevated within 4 hrs (Akmal et al., 
1998b). For this reason, I investigated the effect of RA on the expression of retinoid receptors 
and binding proteins in Schwann cells. 
 
2.4.2 Autoregulatory functions of RA 
Some of the target genes for retinoids are RARs themselves, in particular the RARß gene, 
whose expression is controlled by two promoters (Zelent et al., 1989). The promoter that 
regulates the expression of RARß2 gene is strongly induced by RA in different cell types (de 
The et al., 1990; Sucov et al., 1990). RA-responsive elements have been identified in the 
regulatory regions of several genes involved in retinoid signaling including RARα2, RARβ2, 
RARγ2, CRBP-I and CRABP-II (Piedrafita and Pfahl, 1999). The induction of RARβ is 
thought to play an important role in growth arrest and morphological differentiation of 
embryonal carcinoma cells, human breast cancer cells or neuroblastoma cells (Faria et al., 
1999; Giannini et al., 1997; Liu et al., 1996). The protein expression of retinoid receptors was 
unaffected by RA in Schwann cell primary cultures. Gene expression data of Schwann cells 
showed that mainly RARβ and slightly RARγ were induced after treatment with 100 nM RA 
(Zhelyaznik, 2003). At a concentration of 10 nM RA (which I used during experiments) only 
RARβ gene expression was slightly increased. After sciatic nerve injury gene expression data 
of retinoid receptors showed an upregulation of all RARs and RXRα which was confirmed on 
the protein level only for RARα and RXRα. In the mouse CNS the protein localization of 
several retinoid receptors did not correlate with the distribution of the corresponding RNA 
transcripts (Krezel et al., 1999). These findings suggest that 1. not all elevated genes are 
translated into comparable levels of protein, 2. that other cell types than Schwann cells must 
be involved in RA signaling after sciatic nerve injury and 3. that the doses of applied RA 
seem to play an important role. 
CRABP-II was significantly downregulated after 24 and 48 h. This might represent a 
regulatory mechanism for the responsiveness of Schwann cells to RA. The loss of expression 
of CRABP-II is correlated with resistance of mammary carcinoma cell lines to RA-induced 
growth arrest (Jing et al., 1997), and the expression of a CRABP-II antisense construct in 
stromal stem cells results in reduced sensitivity to RA-induced cell-cycle arrest (Vo and 
Crowe, 1998). Interestingly, the expression of CRABP-II is upregulated in cells that 
synthesize relatively large amounts of RA (Bucco et al., 1997; Yamamoto et al., 1998; Zheng 
et al., 1996), suggesting that an increased physiological need for RA also requires the 
presence of higher CRABP-II levels which, in turn, will allow for efficient and rapid delivery 
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of the hormone to RA. A negative feedback inhibition in case of RA overdose might be 
possible, too. 
 
2.4.3 RA – cytokine interactions 
There are some hints that cytokines participating in traumatic reactions of the nervous system 
are regulated in Schwann cells via RA, as we found with RT-PCR that RA downregulated the 
expression of CNTF in Schwann cell primary cultures to 63 % of control level (Johann et al., 
2003). To test whether RA regulates the expression of other cytokines in Schwann cells I 
performed RNase protection assays and detected NGF, BDNF, GDNF, CNTF, TGFβ1, 
TGFβ2, TGFβ3, IFNβ, IFNγ and MIF gene transcripts. An RA-dependent regulation of some 
of the cytokines detected in other culture systems is recorded and summarized in table 2.2: 
RA induces the transcription of NGF, GDNF, members of the TGFβ family and MIF and 
inhibits CNTF expression. In Schwann cell primary cultures, no differential regulation of 
these cytokines was seen after RA-treatment of 24, 48 and 96 hrs with the RPA. 
 
Table 2.2: Regulation of cytokines by RA. 
 
trophic factor effect of RA  
on expression 
cell system/tissue references 
NGF  
↑ 
↑ 
Schwann cells primary culture 
PC12 cells 
mouse L cells 
present work 
(Scheibe and Wagner, 1992) 
(Wion et al., 1987) 
BDNF 
 
 
 
Schwann cells primary culture 
 
present work 
 
GDNF 
 
 
↑ 
Schwann cells primary culture 
Schwann cells primary culture 
present work 
(Kinameri and Matsuoka, 2003) 
CNTF 
 
 
↓ 
Schwann cells primary culture 
Schwann cells primary culture 
present work 
(Johann et al., 2003) 
TGFβ1,2,3 
 
 
↑ 
↑ 
Schwann cells primary culture 
PC12 cells 
embryonic testis 
present work 
(Cosgaya et al., 1997) 
(Cupp et al., 1999) 
IFNβ 
 
 
 
Schwann cells primary culture 
 
present work 
 
IFNγ 
 
 
 
Schwann cells primary culture 
 
present work 
 
MIF 
 
 
↑ 
Schwann cells primary culture 
murine embryonic stem cells 
present work 
(Sarkar and Sharma, 2002) 
The contradictory results of CNTF and GDNF upregulation in Schwann cells might be due to 
the different methods used. RT-PCR which was used for detection is an amplifying method 
and therefore more sensitive than the RPA. TGFβ data were confirmed with ELISA of 
supernatant of Schwann cell primary cultures: Cells secreted TGFβ but no effect of RA was 
visible (Mey, unpublished observations). Also no influence of IL-6, CNTF or the pro-
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inflammatory cytokine IL-1β on cytokine expression in Schwann cells could be detected. This 
was described in the literature for other cell culture systems (Gross et al., 1993; Kagechika et 
al., 1997; Lindholm et al., 1987; Zitnik et al., 1994). Possibly, cytokines expressed in 
Schwann cells regulate cytokine expression in other cell types, e.g. during Wallerian 
degeneration: axotomy-induced production of TNFα and IL-1α and also delayed IL-1β 
expression in Schwann cells induce IL-6 and GM-CSF production in fibroblasts. Additionally 
they induce recruited macrophages to produce the pro-inflammatory cytokines IL-6, TNFα, 
IL-1α, and IL-1β and the anti-inflammatory cytokine IL-10, which in turn downregulates the 
production of all inflammatory cytokines and itself in all non-neuronal cells (Shamash et al., 
2002). I cannot completely exclude the possibility that the RPA method was too insensitive to 
detect RA-or IL-1-induced changes in gene expression. The absence of any effect of IL-1 is 
disconcerting. 
Since no RA-dependent regulation of cytokine expression in Schwann cells was detectable 
with the RPA experiments, I investigated whether RA plays a role downstream in the 
signaling cascade of trauma-related neuropoietic cytokines and neurotophins, leading to a 
phosphorylation of transcription factors and subsequent gene transcription. The mechanism by 
which RA can cause this activation is still unknown. There are several steps in the cascade at 
which RA may exert an influence (table 2.3): For example it changes the expression of 
cytokine receptors: in the signaling cascade of neuropoietic cytokines RA inhibits IL-6-
dependent signaling in B lymphocytes via downregulation of both membrane and soluble Il-
6R (IL-6 agonists) and the increased production of soluble gp130, an IL-6 antagonist (Zancai 
et al., 2004). Another level of interference displays the modulation of suppressors of cytokine 
signaling (SOCS), that negatively regulate Jak and Stat pathways. SOCS3 is induced by RA 
to inhibit the Jak/Stat pathway in astrocytes (Choi et al., 2005), although no RARE sequences 
in the promoter regions of SOCS3 have been identified to date. RA is also able to affect the 
expression and/or the activity of Stat factors in some cellular systems, as retinoids exerted 
their anti-proliferative activity by regulation of Stat1 and Stat2 (Dimberg et al., 2000; 
Matikainen et al., 1998). Another signaling pathway that can be affected by RA is the 
regulation of the MAP-kinase, which is downstream of neurotrophins. RA upregulates low- 
and high-affinity NGF receptors in immature chick sympathetic neurons (Haskell et al., 
1987). RARα specific retinoids reduce epidermal growth factor receptor expression/activity 
which results in reduced activation of Erk1/2 kinase (Sah et al., 2002). In HL-60 cells RA 
increased a MEK-dependent increase in the amount of phosphorylated Raf (Yen and 
Varvayanis, 2000). It is also likely that RA regulates the synthesis of intermediate proteins 
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indirectly involved in the cytokine signaling pathway. An induction of RA was, for example, 
shown for the expression of MAPK phosphatase 1, which is involved in regulating MAPKs 
(Lee et al., 1999). 
I investigated whether RA treatment changed the phosphorylation status of Stat3 and Erk1/2 
in Schwann cells. Duration of Schwann cell treatment varied between 3 h and 48 h, as during 
this time RA might induce de novo protein synthesis, as described above. I did not see any 
regulatory effect of RA on the phosphorylation status of Stat factors and Erk1/2 within the 
investigated time window. Direct influences of RA on the phosphorylation of the transcription 
factors would imply a rapid activation of the pathway, as most extracellular signals typically 
activate signal transduction pathways within 30 min. Bost and co-workers (2002) found an 
Erk activation in embryonic stem cells only 4 hrs after addition of RA, whereas no 
phosphorylation was seen after 1 h. Contrarily Cañon et al. (2004) found out that RA induced 
Erk1/2 phosphorylation in A126-1B2 cells as soon as 3 min after incubation and was maximal 
at 10 min, decreasing thereafter. So I may have chosen the wrong time window for my 
experiments. It is also possible that RA functions not upstream of neurotrophin signaling, 
Corcoran and Maden (1999) showed the converse, that NGF is upstream of RA and stimulates 
neurite outgrowth of dorsal root ganglia (DRG) via RA, induces transcription of RALDH2 
and RARβ and release of synthesized RA. These experiments indicate that RA is required for 
adult DRG neurite regeneration. NGF activates the RARß2 gene expression also in PC12 cells 
via transcriptional activation involving the Ras-MAPK pathway (Cosgaya and Aranda, 2001). 
 
Table 2.3: Regulation of cytokine signaling factors by RA 
signaling factor effect of RA  
on expression 
cell system/tissue references 
cytokine receptor: 
(soluble) IL-6R 
soluble gp130 
EGFR 
NGFR 
 
↓ 
↓ 
↓ 
↑ 
 
B lymphocytes 
B lymphocytes 
human papillomavirus-positive cell lines
immature chick sympathetic neurons 
 
(Zancai et al., 2004) 
(Zancai et al., 2004) 
(Sah et al., 2002) 
(Haskell et al., 1987; 
Rodríguez-Tébar and 
Rohrer, 1991) 
SOCS 
 
↑ 
 
astrocytes 
 
(Choi et al., 2005) 
 
Raf 
 
↑ HL-60 cells (Yen and Varvayanis, 2000) 
transcription factors: 
Stat1,2 
Stat3 
Erk1/2 
 
↑ 
 
 
 
myeloid leukemia cell lines 
Schwann cell primary culture 
Schwann cell primary culture 
 
(Matikainen et al., 1998) 
present work 
present work 
MKP-1 ↑ 
 
human bronchial epithelial cells (Lee et al., 1999) 
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In summary, I demonstrated that the RA signaling cascade is present in Schwann cells and 
that RA increased the nuclear translocalization of retinoid receptors and CRABP-II. I did not 
detect any impact of RA on cytokine signaling. Therefore the biological significance of 
retinoid receptor expression in Schwann cells remains to be discovered. 
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3 Reactive microglia/macrophages and neurons are targets of retinoic acid signaling 
after spinal cord injury 
 
3.1 Abstract 
Inflammatory reactions after spinal cord injury are accompanied by local synthesis of the 
transcriptional activator retinoic acid (RA). RA exerts its effects by binding to nuclear 
receptors (RAR) which heterodimerize with retinoid X receptors (RXR), and these then act as 
ligand-activated transcription factors. To identify possible cellular targets of RA after CNS 
injury the cellular distribution and protein levels of all retinoid receptors in the rat spinal cord 
were investigated. Changes in these parameters were monitored at 4, 7, 14 and 21 days after 
contusion injury. Immunoreactivity of RARα, RXRα, RXRβ and RXRγ but not of RARβ and 
RARγ was detected. In the non-lesioned spinal cord, immunoreactivity of RARα, RXRα, 
RXRβ and RXRγ was localized in the cytosol of neurons, of RXRα and RXRβ in astrocytes, 
and of RARα, RXRα and RXRγ in some oligodendrocytes. After contusion injury RARα and 
all RXR appeared in the cell nuclei of reactive microglia/macrophages. This nuclear staining 
began at 4 days, was most prominent at 7 and 14 days and had decreased at 21 days after 
injury. A similar change in intracellular distribution was also observed for the RARα, RXRα 
and RXRβ staining in neurons situated around the border of the contusion. The injury-induced 
subcellular translocation was strongest for RARα, while the intracellular distribution of RXRγ 
did not change. Astrocytes and oligodendrocytes were also immunoreactive for retinoid 
receptors. These observations suggest that RA participates as a signal in inflammatory 
reactions after CNS injury. 
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3.2 Material and Methods 
3.2.1 Animal experimentation 
For all experiments 30 male Lewis rats, aged 11 to 15 weeks, were used, 24 for Western blot-
ting and 6 for immunohistochemistry. Spinal cord contusions were performed with the NYU 
impactor device. During operation the rats breathed O2 and N2O, 1:2 ratio with varying con-
centrations of halothane during the procedure, 5% to lose consciousness, 2% until analgesia 
and 1,5 – 1% thereafter. After removing the covering muscle tissue the spinal column was 
opened at vertebrae T10 and T11 without rupturing the dura to expose the spinal cord (Fig. 
3.1). 
The spinal column was fixed with Allis clamps in a stereotactic frame at the spinal processes 
of T9 and T12 and raised to reduce breathing motilities. To induce a mild lesion a weight of 
10 g was dropped from a height of 12.5 mm. The weight drop and displacement of the tissue 
at impact were monitored to ensure reproducibility. Experiments with velocity errors of over 
5% were excluded from the analysis. After the injury, removed vertebral bones were replaced 
by a resorbable gelatin sponge (Spongostan, Ferrosan, Denmark) and muscles and skin were 
sutured. Postoperative care included analgesics (0.1 mg/kg of 0.3mg/ml Temgesic; Schering-
Plough), 5-10 ml daily of Ringers´ lactate, both applied subcutaneously, and manual emptying 
of the bladder until sufficient voiding of the bladder returned. Sham-treated animals received 
a laminectomy only. Locomotor recovery after spinal cord contusion injury was monitored 
using the locomotor rating scale of Basso, Beattie, Bresnahan (Basso et al., 1995) to verify 
that the severity of the injury was consistent in all animals. Animal experiments were 
performed in accordance with legal requirements for animal experimentation, and were 
approved by the local authorities (University of Maastricht). 
 
 
 
 
 
 
 
 
 
 
Fig. 3.1: Laminectomy. For spinal cord contusion injury rat spinal cord was exposed at 
vertebral level T 10 and T 11. 
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3.2.2 Western blotting 
After survival periods of 4, 7, 14 and 21 days rats were killed through decapitation. A 30 mm 
piece of spinal cord was removed and divided into sections 10 mm central, rostral and caudal 
to the lesion. Every piece was triturated in 4 µl/mg of 20 mM HEPES buffer with 1% Triton 
X-100 and protease inhibitors 1 mM PMSF, 1 µM leupeptin, 1% aprotinin. After 20 min 
centrifugation at 13,000 g at 4°C the content of soluble protein extracts was measured with 
the bicinchoninic acid protein assay. Proteins were separated with discontinuous SDS-PAGE 
and transferred onto a nitrocellulose membrane and stained with Ponceau-S. We used rabbit 
antisera binding specifically to the RA-receptor RARα or retinoid X receptors (RXRα, -β, -γ), 
all diluted 1/500. To test the specifity of the RARα antiserum, it was blocked with RARα 
peptide (Santa Cruz, sc-551P): This was diluted 1/50 and pre-incubated with RARα antiserum 
2 hrs before use. Detection of immunoreactivity was based on peroxidase conjugated 
secondary antibodies goat anti-rabbit IgG (1/5000) and goat anti-mouse IgG (1/10000), 
enhanced chemiluminiscence and a digital image analysis system. When evaluating the 
Western blots I used exposure times between 30 sec and 30 min to determine the linear range 
of chemiluminiscence output. For each time point 3 animals receiving a SCI were compared 
to 3 sham-operated animals. For statistics the immunoreactivity values after spinal cord 
contusion were normalized using the averaged data from sham-operated animals with the 
same period of survival. In the quantification experiments, Ponceau-S staining of all proteins 
was used as control when comparing the strengths of specific immunoreactive signals. 
Logarithms of corrected data were analyzed with ANOVA and post-hoc Dunnett’s test. 
 
3.2.3 Immunohistochemistry 
For immunohistochemistry rats were sacrificed using an overdose of 0.8 ml pentobarbital so-
dium (Narcoren, Merial GmbH) after the same survival periods as described above. Rats were 
perfused with 4% PFA, a 10 mm piece of lesioned spinal cord was removed and postfixed 
over night, again in 4% PFA. For cryoprotection the tissue was equilibrated in 15% and 25% 
sucrose for 24 hrs each and then quick-frozen in isopentane. On a cryostat, the spinal cord 
was sectioned parasagittally in 10 µm slices and dry-mounted on ice-cold, gelatin-coated 
slides. To avoid background staining, sections were blocked for 60 min with 3% NGS and 1% 
Triton X-100 for permeabilization. Sections were incubated overnight at 4°C with 
combinations of one primary antibody against a retinoid receptor and one antibody used as a 
cell type marker. Primary antibodies were directed against RARα, RXRα, RXRβ, (diluted 
1/100), RXRγ (1/75), all polyclonal, and monoclonal antibodies against GFAP (1/2000, 
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Sigma), CNPase (1/1000, Sigma), MAP2 (1/500, Sigma) and ED1 (1/600, Serotec). 
Secondary antibodies were Alexa Flour488 goat anti rabbit (1/1000) and Alexa Flour594 goat 
anti mouse (1/500) IgGs. Cell nuclei were visualized with 4’,6-diamidino-2-phenylindole 
dihydrochloride (DAPI, Sigma D9564). Sections were analyzed with fluorescence microscopy 
using a Zeiss axiophot microscope. Again, pre-incubation with antigenic peptide allowed to 
test the specifity of RARα staining in the tissue. 
 
3.2.4 Quantification of the intracellular localization of retinoid receptors 
I evaluated the intracellular distribution of RARα, RXRα, RXRβ and RXRγ in neurons, ED1-
positive microglia/macrophages, astrocytes and oligodendrocytes in spinal cord sections from 
non-operated and lesioned rats at 4, 7, 14 and 21 dpo. DAPI-stained cells were identified by 
their morphology and location in the spinal cord, and their identity was verified with 
immunoreactivity for the markers mentioned above. A quantitative assessment was made for 
neurons and activated microglia/macrophages: for every double labeling condition, three 
sections, separated by 100 µm, were photographed (40 x objective, Zeiss Axiovision 
software). From these photographs 20 ED1- and MAP2-positive cells were randomly selected 
within (macrophages) or close and ventral to the epicenter of the injury (motoneurons). The 
fluorescence values of staining against the retinoid receptor (Alexa Fluor488) of equal sized 
areas within the nucleus and within the cytoplasm were measured with NIH image software 
and the quotient was calculated for every cell. The position of the cell nucleus was determined 
with DAPI, the cell body with Alexa Fluor594 counterstaining (ED1, MAP2). Dependence of 
the nuclear/cytosolic staining ratio on time after injury was evaluated with ANOVA. 
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3.3 Results 
3.3.1 Behavioral effects of spinal cord contusion 
All animals showed injury-induced deficits and a normal pattern of recovery according to the 
score of Basso, Beattie and Bresnahan (BBB). In the first post-operative days only movement 
of the joints in the hind limbs was observed). Thereafter, some degree of recovery occurred, 
such that after three weeks the animals reached an average BBB score of 11. Large 
differences between the animals were not noted (Fig. 3.2: 3 days, BBB score 3.8 ± 1.6, mean 
± SEM; 21 days, 10.8 ± 0.3). The limited improvement in function is part of the normal 
healing process, e.g. reduction of edema, but does not lead to functional recovery which 
would require axonal regeneration. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.2: BBB locomotor rating scale. 
 
3.3.2 Morphological changes after spinal cord injury 
Acute injury to the nervous system triggers a number of morphologic and metabolic changes 
in the directly affected neurons. Injured nerve cells that survived the initial damage rapidly 
stimulate the activation of nearby microglia and astrocytes and frequently undergo apoptosis 
(Raivich et al., 1999). Staining of MAP2, which marks neuronal somata and dendrites, 
showed the complete absence of viable neurons within the lesion site even after mild 
contusion injury (Fig. 3.3). In the non-injured spinal cord, GFAP-positive astrocytes with thin 
processes were evenly distributed over gray and white matter. Four days after injury there 
were no astrocytes left within the lesion site, and adjacent astrocytes had a changed 
morphology with swollen somata and much shorter processes. As GFAP staining was 
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strongly increased, an astrocytic scar formed around the lesion site. While this phenomenon 
seemed to be in progress after 4 dpo, three days later the number of astrocytes had increased 
in the whole tissue, and a delimited scar made of a thin layer of swollen astrocytes surrounded 
the lesion (Fig. 3.3). During the following two weeks the astrocytic scar grew in size. 
Neural injury causes a rapid transformation of highly ramified or resting microglia to acti-
vated microglia with thick processes. Cell death leads to a further transformation into amoe-
boid or reactive microglia, which lose their processes and become phagocytotic. Microglial 
activation is marked by proliferation, migration to the site of injury, morphological changes 
and altered expression of cell surface markers. Spinal cord contusion also disrupts the blood 
brain barrier, thereby causing the infiltration of lymphocytes and hematogenous macrophages 
into the tissue. The ED1 antibody used here recognizes a single chain glycoprotein of 110 
kDa that is expressed predominantly on the lysosomal compartment of activated and reactive 
microglia and macrophages, and it is absent in the normal adult rodent CNS (Dijkstra et al., 
1985; Perry et al., 1993; Streit et al., 1989). At all time points after injury, ED1-positive, 
activated and reactive microglia were seen in the spinal cord sections (Fig 3.3). 
 
 
 
Fig. 3.3: Spinal cord sections seven days after contusion injury. MAP2 stained neurons died 
in the epicenter of the lesion. GFAP-positive astrocytes formed the glial scar and were not 
found within the center of the lesion. ED1-positive macrophages migrated to the site of injury 
to phagocyte myelin debris. c: caudal, v: ventral, r: rostral, d: dorsal. 
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3.3.3 RARα and all RXRs are present in the rat spinal cord 
To address the question, which retinoid receptors are expressed in the adult spinal cord, pro-
tein extracts from intact spinal cord were analyzed with Western blotting. The results showed 
that RARα and all retinoid X receptors were present in the adult rat spinal cord (Fig. 3.4a). 
Immunostaining against RARα showed bands of molecular weights of 105, 80 and 55 kDa 
with one predominant band at 80 kDa. Pre-incubation of the antibody with RARα peptide 
abolished the immunoreactive signals of all three molecular weight bands (Fig. 3.4b) and also 
of a specific signal in tissue sections (see below). The immunoreactive bands of RXRα and –γ 
had a size of 40 kDa and RXRβ of 55 kDa and were consistent with those cited in the 
literature (Takiyama et al., 2004; Mohan et al., 2003). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.4: Retinoid receptor expression in the rat spinal cord. a: Western blot data reveal the 
presence of RARα  and all RXRs in the intact spinal cord. b: Pre-incubation of the antibody 
with RARα peptide abolished the immunoreactive signals of all three molecular weight bands. 
 
3.3.4 SCI causes a small reduction in the amount of retinoid receptor proteins 
If retinoic acid plays a role in lesion-induced processes after spinal cord injury one way of 
regulation of transcriptional activity might consist in changing protein concentrations of its 
receptors, similar to what was observed in peripheral nerves (Zhelyaznik and Mey, 2005). For 
quantitative assessment of the four retinoid receptor types that we found to be expressed in the 
adult spinal cord, animals receiving a SCI were compared with sham-operated animals at time 
points of 4, 7, 14 and 21 days post operation (dpo). Three rats were used for every time point 
and type of injury. Subsequently, a 30 mm piece of spinal cord around the lesion site was 
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dissected and divided into three segments of equal size, central, rostral and caudal to the 
lesion. Semi-quantitative analysis of Western blots revealed a moderate but significant 
reduction in the total amount of RARα and RXRβ central to the lesion at 4, 7 and 14 dpo and 
in the caudal part at 4 dpo (Figs. 3.5, 3.6a,c). 
 
 
 
 
 
 
 
 
 
Fig. 3.5: Seven days after contusion injury: the total amount of RARα, RXRβ and RXRγ was 
reduced after spinal cord injury (sci) central and caudal to the lesion site compared to sham 
operated animals (control: C). RXRα  protein level decreased rostral and in the central part 
of the lesion. 
 
After 21 days, central and caudal of the lesion site the protein levels had returned to baseline. 
In the rostral segment at 21 dpo, an increase of RARα and RXRβ appeared. The amount of 
RXRα (Fig. 3.6b) was reduced significantly at 4 dpo central and caudal to the lesion, at 7 dpo 
rostral and central (see also Fig. 3.5) and at 14 dpo in the caudal segment. RXRγ was 
significantly downregulated only 21 days after injury in each of the three segments of the cord 
(Fig. 3.6d). These changes may have occurred because of a downregulation of retinoid 
receptors within surviving cells or because of degeneration of RAR/RXR expressing cell 
types. This issue was resolved with immunohistochemical analysis. 
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Fig. 3.6: Quantitative analysis of protein expression after spinal cord injury. Immuno-
reactivity levels of a: RARα,  b: RXRα, c: RXRβ and d: RXRγ, quantified with Western 
blotting, normalized to sham operated control animals (C); (n = 3 in all experiments; error 
bars indicate SEM; * p < 0.05, ** p < 0.01).  
 
3.3.5 Cellular distribution of retinoid receptors in the adult spinal cord 
To identify cell types that express retinoid receptors in the spinal cord, their distribution was 
investigated with immunohistochemistry in parasagittal spinal cord sections of non-injured 
animals and 4, 7, 14 and 21 days after contusion injury. In the unlesioned spinal cord there 
was intense immunoreactivity of RARα in larger dendrites and cytoplasm of MAP2 stained 
neurons (Fig. 3.7a-c). This specific immunohistochemical staining against RARα disappeared 
after pre-incubation of the antiserum with the RARα peptide (Fig. 3.8). Neurons were also 
RXRα positive, which was present in cytoplasm, nuclei and dendrites. RXRγ occurred mainly 
in the cytoplasm. A slight expression of RXRβ was seen in the cytoplasm of these neurons.  
Ramified astrocytes, stained with GFAP, expressed RXRβ in their cytoplasmatic processes 
(Fig. 3.7d-f). These were intensely double-labeled cells in the white matter and here predomi-
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nantly at the border to the gray matter. Staining was stronger in the dorsal spinal cord. Astro-
cytes in the gray matter displayed a weaker RXRβ signal. White matter GFAP-positive 
astrocytes were weakly immunoreactive for RXRα. This signal appeared in the cytoplasm 
close to the cell nuclei, but no exclusively nuclear staining of retinoid receptors was observed 
in astrocytes. Some oligodendrocytes also expressed retinoid receptors. Small, distinctly 
CNPase positive cells in the white matter showed RARα, RXRα and RXRγ (Fig. 3.7g-i) and 
a weak RXRβ positive staining in their cytosol.  
 
 
Fig. 3.7: Cellular distribution of retinoid receptors in the adult spinal cord. a-c: In 
uninjured animals RARα (a) is expressed in the neuropil and the cytosol of MAP2 stained 
neurons (b) in the gray matter; c: RARα/MAP2-double labeling plus DAPI staining of cell 
nuclei. d-f: Same section stained against RXRβ (d) and GFAP (e) positive astrocytes in the 
white matter; f: RXRβ/GFAP-double staining plus DAPI. g-i: CNPase (h) positive 
oligodendrocytes in linear fascicles in the white matter do express RXRγ (g); i: 
RXRγ/CNPase-double staining plus DAPI.  Scale bar: 50 µm, same magnification in all 
photographs. 
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Fig. 3.8: Immunohistochemical staining against RARα is abolished by pre-incubating the 
antiserum with RARα peptide. Microglia/macrophages (a, b) and neurons (c, d) were stained 
with RARα antiserum (a, c) or RARα antiserum pre-incubated with RARα peptide (b, d). 
Arrows in d) point to neurons (MAP2 positive), which are now devoid of staining and darker 
than non-specific background in gray matter. Scale bar for a, b marks 20 µm, scale bar for c, 
d 50 µm. 
 
3.3.6 Nuclear localization of retinoid receptors in reactive microglia/macrophages 
Activated microglia was distributed peripheral to the lesion site (Fig. 3.9a), and amoeboid 
reactive microglia/macrophages were close to and within the epicenter of the lesion (Fig. 
3.9b,c). Four days after injury a weak signal of RARα immunoreactivity was seen in the 
nuclei and cytoplasm of these ED1 positive reactive monocytes within the lesion site (Fig. 
3.9e). Three days later, at 7 dpo, a strong signal was present in the nuclei while the cytosolic 
staining was attenuated (Fig. 3.9f). At 14 dpo the nuclear staining had become even more 
intense (Fig. 3.9g). One week later, 21 dpo, it had decreased to a low level (Fig. 3.9h). In 
contrast, RXRα and RXRβ were found predominantly in the cytoplasm of reactive 
microglia/macrophages at 4 dpo (Fig. 3.9i,m), where the RXR staining did not distinguish cell 
nuclei from the surrounding cytoplasm. After 7 (Fig. 3.9j,n) and 14 days (Fig. 3.9k,o) the 
receptors had shifted almost completely into the nucleus. Subsequently RXRα and -β proteins 
appeared to have returned to their initial distribution, because after 21 days the signals were 
again seen in the cytoplasm (Fig. 3.9l,p). Immunoreactivity of RXRγ was present at 4 dpo in 
the cytoplasm (Fig. 3.9q), while the nuclei were almost devoid of staining. Nuclear staining 
was visible at 7 and 14 dpo (Fig. 3.9r,s), but less prominent than that of RARα, RXRα and 
RXRβ. This pattern changed to a weak cytoplasmatic staining at 21 dpo (Fig. 3.9t). Fig. 3.11a 
presents a quantification of these observations: At 4 dpo the nuclear and cytosolic signals of 
all four receptors were about equal. A translocation of RARα into the nuclei of macrophages 
caused the ratio of nuclear/cytosolic staining to increase. This ratio reached 2-3 at 7 and 14 
dpo then it declined to about 1.4 at 21 dpo. Similar, albeit less dramatic changes are apparent 
for the RXRs. In summary, all expressed retinoid receptors showed a shift from a 
cytoplasmatic to a nuclear localization 7 to 14 days after injury and a subsequent decline of 
the nuclear immunoreactivity (see also Fig. 3.12). These observations, which pertain to ED1 
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positive cells within the epicenter of the contusion injury, were statistically significant 
(ANOVA p < 0.0001 for RARα and all RXRs). 
 
 
Fig. 3.9: RARα and all retinoid X receptors shifted into the nuclei of 
microglia/macrophages after spinal cord contusion. a: Staining of an ED1 positive and 
RXRβ negative activated microglia cell, 14 days after injury, distant from the center of the 
lesion. b-d: ED1 and RXRβ positive microglia/macrophages within the lesion site. As shown 
here, observations and quantitative measurements were performed on cells after 
immunohistochemical double-labeling of one retinoid receptor and ED1, combined with 
DAPI staining. e-h: RARα staining, i-l: RXRα, m-p: RXRβ, q-t: RXRγ, all at 4, 7, 14 and 21 
dpo. Scale bar: 20 µm, same magnification in all photographs. 
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3.3.7 Retinoid receptor expression in neurons 
Our investigation of the neuronal localization of retinoid receptors in neurons therefore 
focused on cells in the ventral spinal cord adjacent to the epicenter of the injury. After 4 days 
there was strong RARα immunoreactivity predominantly in the cytoplasm and bigger 
dendrites of neurons positive for MAP2 rostral and distal to the lesion site (Fig. 3.10a,b). 
Three days later, at 7 dpo, this signal appeared also within some cell nuclei (Fig. 3.10c,d). At 
14 dpo RARα had shifted almost completely into the nuclei (Fig. 3.10e,f), while after 21 dpo 
it was again located predominantly in the cytoplasm and bigger dendrites (Fig. 3.10g,h). An 
RXRα signal was present in the cytoplasm, in bigger and smaller dendrites and to a lesser 
extent in neuronal nuclei at 4 dpo. Dendrites were stained more strongly with the antibody 
against RXRα than that against RARα. Seven days post operation the dendritic staining had 
decreased, and it was almost gone after 14 dpo. In contrast, the nuclear staining increased 
during this time. After 21 days the RXRα signal was weak and mostly cytoplasmatic. The 
neuronal staining of RXRβ was in general rather faint, it decreased with time and changed 
from predominantly cytosolic with no distinct dendritic staining at 4 dpo to a more nuclear lo-
cation at 7 and 14 dpo, and then was again mostly cytosolic. The intracellular distribution of 
RXRγ changed less than was observed for the other receptors (Fig. 3.11b). The intensity of 
staining, indicative for the overall amount of receptor protein, decreased from 4 to 7 dpo and 
recovered again after 14 and 21 days. In comparison with macrophages, the intracellular 
distribution of retinoid receptors in neurons always displayed a stronger cytoplasmatic signal. 
Yet, a transient shift of all detected retinoid receptors towards the nucleus did occur 
(ANOVA, p < 0.0001 for RARα and all RXRs). This lesion-induced change was most 
pronounced at 7dpo. For the quantification of these observations motoneurons, identified by 
their size, morphology and location in the ventral horn, were selected. While it is possible that 
the changed retinoid distribution is part of physiological changes that may be detrimental or 
supportive to the further fate of these cells, they exhibited no cytological signs of necrosis or 
apoptosis. The data are shown in Fig. 3.11b and summarized in Fig. 3.12. 
 
3.3.8 Reactive astrocytes in the glial scar are immunoreactive for retinoid receptors 
While in unoperated animals and still at 4 dpo RARα was not present in astroglia, this 
receptor was upregulated in some astrocytes of animals that survived 7 days after injury. The 
receptor protein was discernible in nuclei and cytoplasm, but not in the ramifications of 
astrocytes in gray or white matter. RXRα, in contrast, exhibited a weak staining at all the time 
points after injury that we looked at. It was present in the cytoplasm of swollen astrocytes 
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close to the lesion site, and the intensity of the staining improved with the swelling of the cell 
bodies. At 7 dpo also the nuclei of some of these cells were stained. Two weeks after injury 
many ramified astrocytes in gray and white matter and at the site of injury showed a strong 
RXRα label. Immunostaining in these cells was reduced at 21 dpo. A bright RXRβ signal was 
already visible in many but not all astrocytes of the unoperated spinal cord. The number of 
RXRβ positive astrocytes increased with time, especially close to the lesion site. Most RXRβ 
marked cells were seen 21 dpo (Fig. 3.10i-p).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.10: Spinal cord contusion induces intracellular translocation of RARα in neurons 
and an increase of RXRβ immunoreactivity in astrocytes in the glial scar. a, c, e, g: im-
munostaining against RARα; b, d, f, h: RARα and MAP-2 double labeling plus DAPI nuclear 
staining; i, k, m, o: Immunohistochemistry against RXRβ; j, l, n, p: RXRβ and GFAP double 
labeling plus DAPI staining; same sections in a-b, c-d, e-f, g-h, i-j, k-l, m-n, and o-p. a, b, i, j: 
Sections at 4 dpo, c, d, k, l: 7 dpo, e, f, m, n: 14 dpo, and g, h, o, p: 21 dpo. Photographs of 
neurons (a-h) are from ventral spinal cord close to but not within the site of contusion. Four 
days and 7 dpo RARα staining is present in the neuropil and in the cytosol of neurons, at 14 
dpo cytosolic staining is reduced, and RARα is mainly located within the cell nuclei (arrows 
in e, f). After 21 dpo the signal is again predominantly in the cytoplasm and bigger dendrites 
(arrow in g, h). Photographs of reactive astrocytes (i-p) were made adjacent to the lesion site. 
The number of astrocytes expressing RXRβ increased constantly with time after injury. Scale 
bar: 50 µm, same magnification in all photographs. 
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No intracellular shift towards a nuclear localization was apparent. Compared to the controls, 
RXRγ was upregulated 4 dpo in the cytoplasm of astrocytes in the white matter and around 
the lesion site, and after 7 dpo the receptor was seen also in the nuclei. At 14 dpo RXRγ was 
found in astrocytes in the gray matter adjacent to the lesion site. After 21 days the RXRγ 
signal had again decreased. These observations of retinoid receptor expression in GFAP 
positive astrocytes are summarized in Fig. 3.12. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.11: Quantitative analysis of the intracellular receptor distribution in microglia and 
neurons. a: In microglia all retinoid receptors translocated into the nucleus with a peak at 14 
dpo for RARα, RXRβ and RXRγ and at 7 dpo for RXRα. This intracellular translocation was 
most prominent for RARα where the ratio of nuclear to cytosolic signal rose from 1.1 to 2.7. 
Changes were significant for RARα, and all RXRs (ANOVA, p < 0.0001) b: In neurons, 
RARα, RXRα and RXRβ signals shifted to the nucleus with a maximum at 14 dpo (ANOVA, p 
< 0.0001). Again, RARα showed the strongest nuclear/cytosolic signal ratio. The 
intracellular distribution of RXRγ changed very little. Error bars indicate SEM, n = 20 cells 
in all cases. 
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3.3.9 Retinoid receptor distribution in oligodendrocytes 
In the intact spinal cord CNPase staining of gray and white matter was used to mark oli-
godendrocytes and their processes. The pattern of staining did not change much at 4 dpo. 
Seven and 14 days after injury the CNPase staining was more intense, and the structural dif-
ferences between gray and white matter myelin were better distinguishable. Already at 4 dpo 
a lot of myelin debris, distributed within the entire lesion site, was partially phagocytosed by 
microglia. After 21 dpo this remaining CNPase staining was again weaker and the lesion site 
was almost cleared of myelin debris. 
All analyzed retinoid receptors were co-expressed with CNPase in a pattern that resembled 
that of myelin. The signal of all retinoid receptors increased over time, at 7 and 14 dpo, and 
declined 21 days after lesion. CNPase immunoreactive structures that also carried RARα, 
RXRα and RXRγ occurred in linear fascicles in the white matter, yet most oligodendrocyte 
cell bodies were not immunoreactive for the retinoid receptors. When present, the 
cytoplasmatic signal of RARα and RXRα did not change over time whereas RXRγ 
translocated into the nucleus of some oligodendrocytes between 7 and 14 days after injury 
(Fig. 3.12). RXRβ was not visible in oligodendrocyte cell bodies. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.12: Intracellular localization of retinoid receptors. Schematic representation of the 
distribution (cytoplasm, nucleus) and strength (white = none, gray = average, dark gray = 
strong) of the immunoreactive signals in macrophages/microglia, neurons, scar-forming 
astrocytes and oligodendrocytes. n.d.: no ED1 staining detected. 
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3.4 Discussion 
In this study I found that spinal cord contusion injury in the adult rat causes an intracellular 
translocation of retinoid receptors RARα, RXRα, RXRβ and RXRγ in macrophages and 
neurons. The time course of these changes, predominantly 7-14 days after injury, suggests an 
involvement of retinoic acid signaling in late inflammatory processes. Retinoid receptors were 
also expressed in astroglia and oligodendrocytes, and the staining patterns in these cells were 
similarly affected by the injury. 
Western blotting results showed that RARα and all RXR isoforms were also present in the 
unlesioned spinal cord. Quantitative assessment of the retinoid receptor proteins at 4, 7, 14 
and 21 days after spinal cord injury showed a moderate reduction in the total amount of 
RARα, RXRα and RXRβ central and caudal to the lesion at 4, 7 and 14 dpo. After 21 days 
the protein levels had returned to baseline. RXRγ was significantly reduced only 21 days after 
injury in each of the three segments of the cord. 
 
3.4.1 Cellular targets of retinoic acid signaling after spinal cord contusion 
Immunohistochemical assessment revealed that the reduction in the total amount of retinoid 
receptor protein was due to the degeneration of RAR/RXR expressing cell types and not to the 
downregulation of RARα or RXRs in surviving cells: As observed previously, the mild 
contusion injury (Basso et al., 1995) produced an expanded area of secondary damage, 
resulting in tissue destruction at the epicenter of the lesion, where all neurons had died, while 
a peripheral rim of white matter tracts was spared. Oligodendrocytes underwent apoptosis in 
those white matter tracts that contained degenerating axons. Glial cell death is maximal 8 dpo 
(Shuman et al., 1997), and even oligodendrocytes located at considerable distance from the 
injury died of apoptosis (Crowe et al., 1997). Astrocytes proliferated and produced a network 
of interdigitated processes that encapsulate the lesion, but within the lesion cavity I did not 
detect any GFAP positive astrocytes. Neurons and oligodendrocytes expressed all four 
retinoid receptor types in the uninjured spinal cord and at all measured time points after 
injury. The loss of neurons at the site of the lesion explains the reduction of RARα, RXRα 
and RXRβ in the tissue samples taken from the lesion site, and the spreading apoptotic death 
of oligodendrocytes probably that in the caudal segment. Although MAP2 positive 
motoneurons that expressed retinoid receptors in their nuclei did not show cytological signs of 
death, I cannot exclude the possibility that the receptor translocation forms an early part of a 
cell death pathway. Whatever the function, neurons appear to be targets of retinoid signaling 
after spinal cord injury.  
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The compensating increase of all retinoid receptors at later time points might be due to the 
upregulation of all retinoid receptors in reactive microglia, which strongly proliferated and 
invaded the lesion cavity in great numbers. I conclude from these observations that 
macrophages are also targets of RA signaling. This interpretation is also in accordance with 
recent experiments by Dheen et al. (2005), who demonstrated anti-inflammatory effects of 
brain microglia primary cultures activated with LPS or β-amyloid peptide. 
 
3.4.2 Intracellular translocation of retinoid receptors 
The standard model of RA-dependent gene regulation holds that RAR/RXR heterodimers 
bind to RARE on the DNA where, in the presence of corepressors, they inhibit gene tran-
scription. Retinoid receptors are thought to reside exclusively in the cell nucleus (Braun et al., 
2002a; Chambon, 1996). In contrast, we found that in the non-injured spinal cord retinoid 
receptors were located in the cytoplasm of neurons and glia cells. We saw a transfer of RARα 
and RXRs to the cell nuclei only after contusion injury. While this constitutes a contradiction 
with the original concept, other instances of cytosolic distribution of retinoid receptors have 
recently been reported, e.g. in Sertoli cells (Braun et al., 2002a, b). Cañón and co-workers 
report non-genomic effects of RA like CREB- and ERK-phosphorylation in PC12 cells 
(Cañón et al., 2004), which might reside in the cytosol. 
The injury-induced subcellular translocation of retinoid receptors may either be a 
consequence of RA exposure or may represent a RA-independent, regulatory mechanism that 
renders these cells responsive to RA. Is RA the trigger of subcellular translocation? It was 
recently reported that spinal cord injury, performed as in the present study, resulted in an 
increase of local enzyme activity of RALDH2, presumably leading to local synthesis of all-
trans RA. In accordance with the intracellular shift or RARα, the strongest increase of 
RALDH2 activity occurred 7 to 14 dpo (Mey et al., 2005). Since RXRs can be heterodimeric 
partners of other nuclear receptors [VDR, TR, PPAR; (Chambon, 1996)] their translocation 
may also be caused by transcriptional activators other than RA, i.e. the ligands of these 
receptors. Thyroid hormone, for instance, may be involved in the responses to nerve injury 
(Barakat-Walter, 1999). In another context, TRβ was found to be partially in the cytoplasm 
and transferred to the nucleus upon T3 binding (Zhu et al., 1998). Co-transfected retinoid X 
receptor markedly decreased the rapid shuttling of TRβ between nuclear and cytoplasmatic 
compartments in HeLa cells by maintaining them unliganded within the nucleus (Baumann et 
al., 2001). Also RARs exhibited reduced shuttling in the presence of RXRs suggesting that 
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heterodimerization plays a major role in maintaining the normal cellular distribution of RARs 
(Maruvada et al., 2003; Prüfer et al., 2000).  
Alternatively, are other factors responsible for a nuclear shift of RARα and RXRs? Injury-
related factors that are not ligands of the nuclear hormone receptor super-family may cause 
the intracellular shift of RARα or RXR proteins. In the liver, pro-inflammatory cytokines, e.g. 
IL-1β, influence the subcellular localization and DNA-binding of RARα:RXRβ heterodimers 
(Denson et al., 2000; Ghose et al., 2004). In the spinal cord, cytokines that lead to a transfer of 
retinoid receptors into the nucleus could thereby induce the responsiveness of the affected 
cells to RA. The DNA-binding domains of RARs, RXRs and other hormone receptors can 
serve as nuclear export signals. (Black et al., 2001) and it was also shown that the DNA 
binding domain of RXRs contains a nuclear localization sequence and mediates binding to 
import receptors (Prüfer and Barsony, 2002). 
 
3.4.3 Possible physiological functions of RA after spinal cord injury 
The time course of retinoid signaling suggests that RA does probably not initiate the 
inflammatory reaction or axonal sprouting because these changes occur earlier. Based on 
receptor expression in target cells it is tempting to conclude that RA may fulfill 
neuroprotective functions. This has already been shown in vitro in different contexts, 
including mouse DRG neurons (Corcoran et al., 2000; Corcoran and Maden, 1999), 
embryonic spinal cord of humans and mice (Quinn and De Boni, 1991), and chick retinal 
ganglion cells (Mey and Rombach, 1999). In vivo, RA increased trkA mRNA levels of 
sympathetic neurons during development, which is needed to acquire dependency on the 
survival factor NGF (Holst et al., 1997). 
In astrocytes, RA might suppress the astroglial inflammatory response. For instance, it has re-
cently been discovered that RA inhibited IFN-γ-activated Jak/Stat pathways, probably via the 
expression of SOCS3 (Choi et al., 2005). In addition to degeneration of their motoneurons 
retinoid deficient rats show an increase in astrocytosis which was found to be a consequence 
of the lack of RARα (Corcoran et al., 2002b). Besides, astrocytes have been suggested to 
regulate the concentration of RA through oxidation of retinol to the biologically active RA, 
which then gives trophic support to spinal cord neurons in vitro (Wuarin et al., 1990). 
In macrophages, which were found to be the main targets of RA signaling after SCI, potent 
anti-inflammatory effects of RA have also been reported. In peritoneal macrophages, RA in-
hibited almost completely the production of tumor necrosis factor, nitric oxide (Sjöberg et al., 
1992), the lipopolysaccharid-induced production of prostaglandin E2 and expression of COX-
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2 protein, which take part in pro-inflammatory reactions as well (Kim et al., 2004). In 
activated rat microglia the RA-induced reduction of the expression of TNFα, and inducible 
nitric oxide synthase was correlated with enhanced expression of RARβ and TGF-β1 and 
inhibited translocation of and NF-κB (Dheen et al., 2004). Therefore, RA might contribute to 
the termination of inflammatory response in the CNS. 
 
In summary, these experiments demonstrate that the RA signaling system participates in the 
physiological responses to SCI: They show that activated microglia in their phagocytotic 
stage are the most prominent targets of this signaling pathway. In addition, neurons, scar 
forming astrocytes and oligodendrocytes express retinoid receptors. The intracellular 
distribution of several of these receptors indicates a RA- or cytokine-mediated translocation 
from the cytosol into the nucleus, which is triggered by a contusion injury. RA signaling may 
thus provide a novel target for therapeutic interventions of inflammatory processes in the 
CNS. 
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4 General discussion 
 
Nerve injury leads to a series of molecular and cellular responses which are fundamentally 
different in the peripheral and central nervous system. In the PNS they can cause a successful 
regenerative response and functional recovery. This is among other factors a consequence of 
the cell types expressed in each of these compartments of the nervous system (CNS: 
astrocytes, oligodendrocytes, microglia; PNS: Schwann cells, macrophages, fibroblasts) and 
the different intercellular signaling pathways between these cell types.  
With respect to retinoic acid signaling a number of similarities and differences are observed 
after injury in the central and peripheral nervous system. In both cases, RA synthesis was 
catalyzed by RALDH2, while RALDH1 and –3 seem not involved. A small lesion-induced 
increase in immunoreactivity or enzyme activity of RALDH2 was seen, which was stronger 
after spinal cord contusion (Mey et al., 2005) than after sciatic nerve injury (Zhelyaznik et al., 
2003). In the spinal cord as well as in the sciatic nerve RARα and all RXRs were expressed. 
After peripheral nerve lesion, nuclear translocation of RARα and RXRα in macrophages and 
Schwann cells was also visible, and as in the spinal cord this activity appeared much later than 
the initial inflammatory response (Zhelyaznik and Mey, 2005 and unpublished observations). 
Different from the sciatic nerve I saw no increase in the expression levels of retinoid receptors 
in the CNS (Zhelyaznik and Mey, 2005). Sources of RA-synthesis in the spinal cord were 
oligodendrocytes, meningeal cells and, after injury, NG-2 expressing cells (Mey et al., 2005), 
which proliferate and are thought to differentiate mostly to oligodendrocytes (Aguirre et al., 
2004; Nishiyama et al., 2002). In the PNS the RA-releasing cells have not yet been identified, 
although RALDH2 staining suggests Schwann cells to be likely candidates. 
Even though my immunohistochemical studies of RARα expression point to likely targets of 
this signaling pathway after injury, at this time the physiological functions of RA are not 
resolved. Besides its putative neuroprotective and anti-inflammatory role RA might be 
involved in the regulation of glial re-differentiation after injury. After sciatic nerve lesion 
CRBP-I and CRABP-II expression was upregulated in the first days followed by a 
downregulation concomitantly with the re-differentiation of Schwann cells during subsequent 
regeneration. This downregulation did not occur in degenerating transected nerves 
(Zhelyaznik et al., 2003). Thus RA might regulate the state of Schwann cell differentiation. In 
cell culture, RA affects monocyte differentiation (Kreutz et al., 1998). OLN93 cells, which 
represent a model for immature oligodendrocytes, express RALDH2 and are able to 
synthesize RA (Mey and Hammelmann, 2000). These cells are concurrently able to respond to 
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RA: gene expression of LIF was 3-fold upregulated in OLN93 cells after RA treatment (Mey 
and Henkes, 2002). It might therefore also be possible that RA promotes cell differentiation of 
oligodendrocytes. In addition, my experiments indicate that astrocytes may belong to the 
targets of RA as well. For instance, RA has been reported to induce the release of NGF from 
cortical astrocytes in vitro (Ahlemeyer et al., 2000). Such effects on transcription of cytokine 
and neurotrophin genes were investigated in this work for glia of the PNS, i.e. Schwann cells. 
Although I monitored the expression of many inflammatory and regeneration-associated 
cytokines, no such function was discovered. 
The discrepancy between reported regulatory properties of RA in other cell culture systems 
and their non-regulation in Schwann cell primary cultures might be due to the fact that other 
contributing factors are involved. For example, treatment of cultured Schwann cells with a 
combination of bone morphogenetic protein-2 (BMP2) and RA dramatically induced GDNF-
mRNA, while BMP2 or RA alone had no effect (Kinameri and Matsuoka, 2003). 
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5 Summary 
 
Experiments with sciatic nerve lesions and spinal cord contusions have demonstrated that 
retinoic acid is involved in the physiological reactions after PNS and CNS injuries. The aim 
of this thesis was to identify the cellular targets of injury-related RA signals in the peripheral 
and central nervous system and to investigate the functional significance of RA in this 
context. 
I discovered that crucial components of the RA signal transduction cascade (retinoic acid 
receptors, retinoid X receptors, RALDH2, Cyp26A1, CRABP-II) were present in Schwann 
cell primary cultures isolated from newborn rats. After RA treatment the spatial distribution 
of RXRs and CRABP-II but not from RARs changed from a cytosolic to a nuclear 
localization, and CRABP-II was downregulated via RA. In the search for possible genetic 
targets of RA signaling I detected that NGF, BDNF, GDNF, CNTF, TGFβ1, TGFβ2, TGFβ3, 
IFNβ, IFNγ and MIF were expressed in Schwann cells. No differential regulation via RA or 
activation of intracellular signaling cascades of neuropoietic cytokines or neurotrophins was 
seen. 
Spinal cord contusion injuries were performed to identify possible cellular targets of RA after 
damage of the CNS. Cellular distribution and protein levels of all retinoid receptors in the rat 
spinal cord were investigated 4, 7, 14 and 21 days after injury. I detected immunoreactivity of 
RARα, RXRα, RXRβ and RXRγ. In the non-lesioned spinal cord, immunoreactivity of 
RARα, RXRα, RXRβ and RXRγ was localized in the cytosol of neurons, of RXRα and 
RXRβ in astrocytes, and of RARα, RXRα and RXRγ in some oligodendrocytes. After 
contusion injury a transient nuclear shift of RARα and of all RXR was visible in reactive 
microglia/macrophages. This nuclear staining, already seen at 4 days, was most prominent at 
7 and 14 days after injury. A similar change in intracellular distribution was also observed for 
the RARα, RXRα and RXRβ staining in neurons situated around the border of the contusion. 
The injury-induced subcellular translocation was strongest for RARα, while the intracellular 
distribution of RXRγ did not change. 
While the identification of the cellular targets of RA signaling confirm the hypothesis of an 
involvement of RA in nerve injury-related processes, the functional significance of RA 
signaling in Schwann cells remains to be elucidated. In the CNS it seems likely that RA 
fulfills neuroprotective functions and contributes to the termination of the inflammatory 
response. A complete understanding of these processes might help to develop strategies to 
heal neurodegenerative diseases and traumatic injuries. 
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